generated by bibbase.org
  2025 (1)
The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics. Andes, D.; Brüggemann, R. J.; Flanagan, S.; Lepak, A. J.; Lewis, R. E.; Ong, V.; Rubino, C. M.; and Sandison, T. Journal of Antimicrobial Chemotherapy, 80(1): 18 – 28. 2025. Cited by: 2; All Open Access, Green Open Access, Hybrid Gold Open Access
The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics [link]Paper   doi   link   bibtex  
  2024 (6)
Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes. Matsuo, T.; Wurster, S.; Jiang, Y.; Sasaki, K.; Tarrand, J.; Lewis, R. E.; and Kontoyiannis, D. P. Journal of Antimicrobial Chemotherapy, 79(2): 297 – 306. 2024. Cited by: 8
Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes [link]Paper   doi   link   bibtex  
Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria. Lewis, R. E.; Palombo, M.; Diani, E.; Secci, B.; Gibellini, D.; and Gaibani, P. Cells, 13(16). 2024. Cited by: 1; All Open Access, Gold Open Access, Green Open Access
Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria [link]Paper   doi   link   bibtex  
Identification and validation of diagnostic cutoffs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients. Bettelli, F.; Vallerini, D.; Lagreca, I.; Barozzi, P.; Riva, G.; Nasillo, V.; Paolini, A.; D’Amico, R.; Forghieri, F.; Morselli, M.; Pioli, V.; Gilioli, A.; Giusti, D.; Messerotti, A.; Bresciani, P.; Cuoghi, A.; Colaci, E.; Marasca, R.; Pagano, L.; Candoni, A.; Maertens, J.; Viale, P.; Mussini, C.; Manfredini, R.; Tagliafico, E.; Sarti, M.; Trenti, T.; Lewis, R.; Comoli, P.; Eccher, A.; Luppi, M.; and Potenza, L. PLoS ONE, 19(7 July). 2024. Cited by: 1; All Open Access, Gold Open Access, Green Open Access
Identification and validation of diagnostic cutoffs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients [link]Paper   doi   link   bibtex  
The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research. Lewis, R. E. Journal of Fungi, 10(6). 2024. Cited by: 0; All Open Access, Gold Open Access, Green Open Access
The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research [link]Paper   doi   link   bibtex  
Triazole antifungal drug interactions - Practical considerations for excellent prescribing. Lewis, R.; Niazi-Ali, S.; McIvor, A.; Kanj, S. S; Maertens, J.; Bassetti, M.; Levine, D.; Groll, A. H; and Denning, D. W Journal of Antimicrobial Chemotherapy, 79(6): 1203 – 1217. 2024. Cited by: 2
Triazole antifungal drug interactions - Practical considerations for excellent prescribing [link]Paper   doi   link   bibtex  
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good?. Lewis, R. E.; and Stanzani, M. Clinical Microbiology and Infection, 30(12): 1503 – 1504. 2024. Cited by: 0
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good? [link]Paper   doi   link   bibtex  
  2023 (6)
Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress?. Lewis, R. E.; Stanzani, M.; Morana, G.; and Sassi, C. Current Opinion in Infectious Diseases, 36(4): 250 – 256. 2023. Cited by: 8; All Open Access, Green Open Access, Hybrid Gold Open Access
Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress? [link]Paper   doi   link   bibtex  
Successful Treatment of Paecilomyces variotii Pneumonia and Lupus Nephritis with Posaconazole-Cyclophosphamide Co-administration Without Drug Interaction-Induced Toxicity. Pechacek, J.; Webb, T.; Ferre, E. M. N.; Schmitt, M. M.; Dimaggio, T.; Kobrin, D.; Rajasimhan, S.; Colton, B.; Lewis, R. E; Andes, D.; Herrera, A.; Hammoud, D.; Seyedmousavi, S.; Hasni, S.; Bolaños, J.; Afzali, B.; and Lionakis, M. S. Open Forum Infectious Diseases, 10(8). 2023. Cited by: 0; All Open Access, Gold Open Access, Green Open Access
Successful Treatment of Paecilomyces variotii Pneumonia and Lupus Nephritis with Posaconazole-Cyclophosphamide Co-administration Without Drug Interaction-Induced Toxicity [link]Paper   doi   link   bibtex  
Preface. Tsakris, A.; Hurley, J.; Johnson, A.; and Lewis, R. Journal of Antimicrobial Chemotherapy, 78: I1. 2023. Cited by: 0
Preface [link]Paper   doi   link   bibtex  
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists : Endorsed by the Mycoses Study Group Education and Research Consortium. McCreary, E. K.; Davis, M. R.; Narayanan, N.; Andes, D. R.; Cattaneo, D.; Christian, R.; Lewis, R. E.; Watt, K. M.; Wiederhold, N. P.; and Johnson, M. D. Pharmacotherapy, 43(10): 1043 – 1050. 2023. Cited by: 33; All Open Access, Bronze Open Access
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists : Endorsed by the Mycoses Study Group Education and Research Consortium [link]Paper   doi   link   bibtex  
Systemic antifungal agents. Lewis, R. E.; and Wiederhold, N. P. 2023. Cited by: 1
Systemic antifungal agents [link]Paper   doi   link   bibtex  
Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia. Lewis, R. E.; and Stanzani, M. Current Fungal Infection Reports, 17(3): 250 – 261. 2023. Cited by: 0; All Open Access, Hybrid Gold Open Access
Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia [link]Paper   doi   link   bibtex  
  2022 (9)
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp. Viciani, E.; Gaibani, P.; Castagnetti, A.; Liberatore, A.; Bartoletti, M.; Viale, P.; Lazzarotto, T.; Ambretti, S.; Lewis, R.; and Cricca, M. International Journal of Infectious Diseases, 117: 233 – 240. 2022. Cited by: 15; All Open Access, Gold Open Access, Green Open Access
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp. [link]Paper   doi   link   bibtex  
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales. Bartoletti, M.; Antonelli, A.; Bussini, L.; Corcione, S.; Giacobbe, D. R.; Marconi, L.; Pascale, R.; Dettori, S.; Shbaklo, N.; Ambretti, S.; Gaibani, P.; Giani, T.; Coppi, M.; Bassetti, M.; De Rosa, F. G.; Marchese, A.; Cavallo, R.; Lewis, R.; Rossolini, G. M.; Viale, P.; and Giannella, M. Clinical Microbiology and Infection, 28(9): 1290.e1 – 1290.e4. 2022. Cited by: 10; All Open Access, Bronze Open Access
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales [link]Paper   doi   link   bibtex  
Quandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosis. Colombo, A. L.; De Almeida, J. N.; Lewis, R. E.; and Kontoyiannis, D. P. Journal of Antimicrobial Chemotherapy, 77(11): 2897 – 2900. 2022. Cited by: 3
Quandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosis [link]Paper   doi   link   bibtex  
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters. Parisi, S.; Ruggeri, L.; Dan, E.; Rizzi, S.; Sinigaglia, B.; Ocadlikova, D.; Bontadini, A.; Giudice, V.; Urbani, E.; Ciardelli, S.; Sartor, C.; Cristiano, G.; Nanni, J.; Zannoni, L.; Chirumbolo, G.; Arpinati, M.; Lewis, R. E.; Bonifazi, F.; Marconi, G.; Martinelli, G.; Papayannidis, C.; Paolini, S.; Velardi, A.; Cavo, M.; Lemoli, R. M.; and Curti, A. Frontiers in Immunology, 12. 2022. Cited by: 8; All Open Access, Gold Open Access, Green Open Access
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters [link]Paper   doi   link   bibtex  
Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association. Stemler, J.; de Jonge, N.; Skoetz, N.; Sinkó, J.; Brüggemann, R. J; Busca, A.; Ben-Ami, R.; Ráčil, Z.; Piechotta, V.; Lewis, R.; and Cornely, O. A The Lancet Haematology, 9(5): e361 – e373. 2022. Cited by: 47
Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association [link]Paper   doi   link   bibtex  
Liposomal amphotericin B-the future. Hoenigl, M.; Lewis, R.; van de Veerdonk, F.; Verweij, P.; and Cornely, O. Journal of Antimicrobial Chemotherapy, 77: II21 – II34. 2022. Cited by: 9; All Open Access, Green Open Access, Hybrid Gold Open Access
Liposomal amphotericin B-the future [link]Paper   doi   link   bibtex  
Key Considerations for Managing Infections in the Compromised Host. Shelburne, S. A.; Lewis, R. E.; and Kontoyiannis, D. P. 2022. Cited by: 0
Key Considerations for Managing Infections in the Compromised Host [link]Paper   doi   link   bibtex  
Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective. Lamoth, F.; Lewis, R. E.; and Kontoyiannis, D. P. Clinical Infectious Diseases, 75(3): 534 – 544. 2022. Cited by: 56
Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective [link]Paper   doi   link   bibtex  
Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study. Pascale, R.; Bussini, L.; Gaibani, P.; Bovo, F.; Fornaro, G.; Lombardo, D.; Ambretti, S.; Pensalfine, G.; Appolloni, L.; Bartoletti, M.; Tedeschi, S.; Tumietto, F.; Lewis, R.; Viale, P.; and Giannella, M. Infection Control and Hospital Epidemiology, 43(4): 461 – 466. 2022. Cited by: 52; All Open Access, Green Open Access, Hybrid Gold Open Access
Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study [link]Paper   doi   link   bibtex  
  2021 (15)
Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study. Glampedakis, E.; Cassaing, S.; Fekkar, A.; Dannaoui, E.; Bougnoux, M.; Bretagne, S.; Neofytos, D.; Schreiber, P. W; Hennequin, C.; Morio, F.; Shadrivova, O.; Bongomin, F.; Fernández-Ruiz, M.; Bellanger, A. P.; Arikan-Akdagli, S.; Erard, V.; Aigner, M.; Paolucci, M.; Khanna, N.; Charpentier, E.; Bonnal, C.; Brun, S.; Gabriel, F.; Riat, A.; Zbinden, R.; Le Pape, P.; Klimko, N.; Lewis, R. E; Richardson, M.; İnkaya, A. C.; Coste, A. T; Bochud, P.; and Lamoth, F. Clinical Infectious Diseases, 72(8): 1379 – 1385. 2021. Cited by: 31; All Open Access, Green Open Access
Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study [link]Paper   doi   link   bibtex  
The lower respiratory tract microbiome of critically ill patients with COVID-19. Gaibani, P.; Viciani, E.; Bartoletti, M.; Lewis, R. E.; Tonetti, T.; Lombardo, D.; Castagnetti, A.; Bovo, F.; Horna, C. S.; Ranieri, M.; Viale, P.; Re, M. C.; and Ambretti, S. Scientific Reports, 11(1). 2021. Cited by: 55; All Open Access, Gold Open Access, Green Open Access
The lower respiratory tract microbiome of critically ill patients with COVID-19 [link]Paper   doi   link   bibtex  
Preface. Perry, J. D; Hope, R.; and Lewis, R. Journal of Antimicrobial Chemotherapy, 76: IV1. 2021. Cited by: 0; All Open Access, Green Open Access, Hybrid Gold Open Access
Preface [link]Paper   doi   link   bibtex  
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Verweij, P. E.; Brüggemann, R. J. M.; Azoulay, E.; Bassetti, M.; Blot, S.; Buil, J. B.; Calandra, T.; Chiller, T.; Clancy, C. J.; Cornely, O. A.; Depuydt, P.; Koehler, P.; Lagrou, K.; de Lange, D.; Lass-Flörl, C.; Lewis, R. E.; Lortholary, O.; Liu, P. L.; Maertens, J.; Nguyen, M. H.; Patterson, T. F.; Rijnders, B. J. A.; Rodriguez, A.; Rogers, T. R.; Schouten, J. A.; Wauters, J.; van de Veerdonk, F. L.; and Martin-Loeches, I. Intensive Care Medicine, 47(8): 819 – 834. 2021. Cited by: 126; All Open Access, Green Open Access, Hybrid Gold Open Access
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis [link]Paper   doi   link   bibtex  
Breakthrough mucormycosis developing on mucorales-active antifungals portrays a poor prognosis in patients with hematologic cancer. Axell-House, D. B.; Wurster, S.; Jiang, Y.; Kyvernitakis, A.; Lewis, R. E.; Tarrand, J. J.; Raad, I. I.; and Kontoyiannis, D. P. Journal of Fungi, 7(3). 2021. Cited by: 23; All Open Access, Gold Open Access, Green Open Access
Breakthrough mucormycosis developing on mucorales-active antifungals portrays a poor prognosis in patients with hematologic cancer [link]Paper   doi   link   bibtex  
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study. Rinaldi, M.; Bartoletti, M.; Ferrarese, A.; Franceschini, E.; Campoli, C.; Coladonato, S.; Pascale, R.; Tedeschi, S.; Gatti, M.; Cricca, M.; Ambretti, S.; Siniscalchi, A.; Morelli, M. C.; Cescon, M.; Cillo, U.; Di Benedetto, F.; Burra, P.; Mussini, C.; Cristini, F.; Lewis, R.; Viale, P.; and Giannella, M. Transplant Infectious Disease, 23(4). 2021. Cited by: 14; All Open Access, Green Open Access
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study [link]Paper   doi   link   bibtex  
Reply to Day et al. Johnson, M. D; Lewis, R. E; Dodds Ashley, E. S; Perfect, J. R; and Kontoyiannis, D. P Journal of Infectious Diseases, 224(9): 1627 – 1628. 2021. Cited by: 1; All Open Access, Green Open Access
Reply to Day et al [link]Paper   doi   link   bibtex  
Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?. Gudiol, C.; Lewis, R. E; Strati, P.; and Kontoyiannis, D. P The Lancet Haematology, 8(3): e216 – e228. 2021. Cited by: 52
Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection? [link]Paper   doi   link   bibtex  
Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis. Lamoth, F.; Lewis, R. E; Walsh, T. J; and Kontoyiannis, D. P Journal of Infectious Diseases, 224(10): 1631 – 1640. 2021. Cited by: 58; All Open Access, Green Open Access, Hybrid Gold Open Access
Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis [link]Paper   doi   link   bibtex  
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study. Giannella, M.; Freire, M.; Rinaldi, M.; Abdala, E.; Rubin, A.; Mularoni, A.; Gruttadauria, S.; Grossi, P.; Shbaklo, N.; Tandoi, F.; Ferrarese, A.; Burra, P.; Fernandes, R.; Aranha Camargo, L. F.; Asensio, A.; Alagna, L.; Bandera, A.; Simkins, J.; Abbo, L.; Halpern, M.; Santana Girao, E.; Valerio, M.; Muñoz, P.; Fernandez Yunquera, A.; Statlender, L.; Yahav, D.; Franceschini, E.; Graziano, E.; Morelli, M. C.; Cescon, M.; Viale, P.; Lewis, R.; Bartoletti, M.; Pascale, R.; Campoli, C.; Coladonato, S.; Cristini, F.; Tumietto, F.; Siniscalchi, A.; Laici, C.; Ambretti, S.; Romagnoli, R.; De Rosa, F. G.; Muscatello, A.; Mangioni, D.; Gori, A.; Antonelli, B.; Dondossola, D.; Rossi, G.; Invernizzi, F.; Peghin, M.; Cillo, U.; Mussini, C.; Benedetto, F. D.; Terrabuio, D. R. B.; Bittante, C. D; Toniolo, A. D. R.; Balbi, E.; Garcia, J. H. P.; Morrás, I.; Ramos, A.; Cruz, A. F.; and Salcedo, M. Clinical Infectious Diseases, 73(4): E955 – E966. 2021. Cited by: 32
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study [link]Paper   doi   link   bibtex  
Epidemiology of Invasive Pulmonary Aspergillosis among Intubated Patients with COVID-19: A Prospective Study. Bartoletti, M.; Pascale, R.; Cricca, M.; Rinaldi, M.; Maccaro, A.; Bussini, L.; Fornaro, G.; Tonetti, T.; Pizzilli, G.; Francalanci, E.; Giuntoli, L.; Rubin, A.; Moroni, A.; Ambretti, S.; Trapani, F.; Vatamanu, O.; Ranieri, V. M.; Castelli, A.; Baiocchi, M.; Lewis, R.; Giannella, M.; and Viale, P. Clinical Infectious Diseases, 73(11): E3606 – E3614. 2021. Cited by: 327; All Open Access, Green Open Access, Hybrid Gold Open Access
Epidemiology of Invasive Pulmonary Aspergillosis among Intubated Patients with COVID-19: A Prospective Study [link]Paper   doi   link   bibtex  
Role and interpretation of antifungal susceptibility testing for the management of invasive fungal infections. Lamoth, F.; Lewis, R. E.; and Kontoyiannis, D. P. Journal of Fungi, 7(1): 1 – 21. 2021. Cited by: 44; All Open Access, Gold Open Access, Green Open Access
Role and interpretation of antifungal susceptibility testing for the management of invasive fungal infections [link]Paper   doi   link   bibtex  
Preface. Lewis, R.; Enne, V. I.; and Ostrosky-Zeichner, L. Journal of Antimicrobial Chemotherapy, 76: I1. 2021. Cited by: 0; All Open Access, Bronze Open Access
Preface [link]Paper   doi   link   bibtex  
Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study. Stanzani, M.; Sassi, C.; Lewis, R.; Sartor, C.; Rasetto, G.; Cavo, M.; and Battista, G. Journal of Infection, 83(3): 371 – 380. 2021. Cited by: 7
Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study [link]Paper   doi   link   bibtex  
Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions. Lewis, R. E.; and Andes, D. R. Current Opinion in Infectious Diseases, 34(4): 288 – 296. 2021. Cited by: 9; All Open Access, Green Open Access
Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions [link]Paper   doi   link   bibtex  
  2020 (10)
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma. Tolomelli, G.; Mancuso, K.; Tacchetti, P.; Patriarca, F.; Galli, M.; Pantani, L.; Zannetti, B.; Motta, M. R.; Rizzi, S.; Dan, E.; Sinigaglia, B.; Giudice, V.; Olmo, A.; Arpinati, M.; Chirumbolo, G.; Fanin, R.; Lewis, R. E.; Paris, L.; Bonifazi, F.; Cavo, M.; Curti, A.; and Lemoli, R. M. Bone Marrow Transplantation, 55(5): 946 – 954. 2020. Cited by: 3
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma [link]Paper   doi   link   bibtex  
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study. Bartoletti, M.; Baldassarre, M.; Domenicali, M.; Lewis, R. E.; Giannella, M.; Antognoli, A.; Rinaldi, M.; Zaccherini, G.; Verucchi, G.; Marconi, L.; Tamè, M.; Berardi, S.; Napoli, L.; Siniscalchi, A.; Fabbri, A.; Biselli, M.; Tufoni, M.; Pavarin, R. M.; Trevisani, F.; Viale, P.; Bernardi, M.; and Caraceni, P. Open Forum Infectious Diseases, 7(11). 2020. Cited by: 10; All Open Access, Gold Open Access, Green Open Access
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study [link]Paper   doi   link   bibtex  
Infectious disease consultation for candidaemia. Lewis, R. E; and Kontoyiannis, D. P The Lancet Infectious Diseases, 20(2): 164. 2020. Cited by: 0
Infectious disease consultation for candidaemia [link]Paper   doi   link   bibtex  
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections. Zaghi, I.; Gaibani, P.; Campoli, C.; Bartoletti, M.; Giannella, M.; Ambretti, S.; Viale, P.; and Lewis, R. Clinical Microbiology and Infection, 26(10): 1338 – 1344. 2020. Cited by: 9; All Open Access, Bronze Open Access
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections [link]Paper   doi   link   bibtex  
Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium. Johnson, M. D.; Lewis, R. E.; Dodds Ashley, E. S.; Ostrosky-Zeichner, L.; Zaoutis, T.; Thompson, G. R.; Andes, D. R.; Walsh, T. J.; Pappas, P. G.; Cornely, O. A.; Perfect, J. R.; and Kontoyiannis, D. P. Journal of Infectious Diseases, 222: S175 – S198. 2020. Cited by: 109; All Open Access, Green Open Access
Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium [link]Paper   doi   link   bibtex  
Chimeric antigen receptor T-cell immunotherapy and need for prophylaxis for invasive mold infections. Lewis, R. E.; and Kontoyiannis, D. P. Clinical Infectious Diseases, 71(7): 1802 – 1803. 2020. Cited by: 16; All Open Access, Green Open Access
Chimeric antigen receptor T-cell immunotherapy and need for prophylaxis for invasive mold infections [link]Paper   doi   link   bibtex  
Combination antifungal therapy for breakthrough invasive mould disease in patients with haematological malignancies: When management reasoning eclipses evidence-based medicine. Garcia-Vidal, C.; Lewis, R.; and Kontoyiannis, D. Journal of Antimicrobial Chemotherapy, 75(11): 3096 – 3098. 2020. Cited by: 2; All Open Access, Bronze Open Access
Combination antifungal therapy for breakthrough invasive mould disease in patients with haematological malignancies: When management reasoning eclipses evidence-based medicine [link]Paper   doi   link   bibtex  
Ceftolozane-tazobactam treatment of hypervirulent multidrug resistant pseudomonas aeruginosa infections in neutropenic patients. Coppola, P. E.; Gaibani, P.; Sartor, C.; Ambretti, S.; Lewis, R. E.; Sassi, C.; Pignatti, M.; Paolini, S.; Curti, A.; Castagnetti, F.; Ursi, M.; Cavo, M.; and Stanzani, M. Microorganisms, 8(12): 1 – 11. 2020. Cited by: 5; All Open Access, Gold Open Access, Green Open Access
Ceftolozane-tazobactam treatment of hypervirulent multidrug resistant pseudomonas aeruginosa infections in neutropenic patients [link]Paper   doi   link   bibtex  
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Verweij, P. E.; Rijnders, B. J. A.; Brüggemann, R. J. M.; Azoulay, E.; Bassetti, M.; Blot, S.; Calandra, T.; Clancy, C. J.; Cornely, O. A.; Chiller, T.; Depuydt, P.; Giacobbe, D. R.; Janssen, N. A. F.; Kullberg, B.; Lagrou, K.; Lass-Flörl, C.; Lewis, R. E.; Liu, P. W.; Lortholary, O.; Maertens, J.; Martin-Loeches, I.; Nguyen, M. H.; Patterson, T. F.; Rogers, T. R.; Schouten, J. A.; Spriet, I.; Vanderbeke, L.; Wauters, J.; and van de Veerdonk, F. L. Intensive Care Medicine, 46(8): 1524 – 1535. 2020. Cited by: 310; All Open Access, Green Open Access, Hybrid Gold Open Access
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion [link]Paper   doi   link   bibtex  
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study. Giannella, M.; Pascale, R.; Pancaldi, L.; Monari, C.; Ianniruberto, S.; Malosso, P.; Bussini, L.; Bartoletti, M.; Tedeschi, S.; Ambretti, S.; Lewis, R.; and Viale, P. Clinical Microbiology and Infection, 26(7): 897 – 903. 2020. Cited by: 37
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study [link]Paper   doi   link   bibtex  
  2019 (19)
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Cornely, O. A; Alastruey-Izquierdo, A.; Arenz, D.; Chen, S. C A; Dannaoui, E.; Hochhegger, B.; Hoenigl, M.; Jensen, H. E; Lagrou, K.; Lewis, R. E; Mellinghoff, S. C; Mer, M.; Pana, Z. D; Seidel, D.; Sheppard, D. C; Wahba, R.; Akova, M.; Alanio, A.; Al-Hatmi, A. M S; Arikan-Akdagli, S.; Badali, H.; Ben-Ami, R.; Bonifaz, A.; Bretagne, S.; Castagnola, E.; Chayakulkeeree, M.; Colombo, A. L; Corzo-León, D. E; Drgona, L.; Groll, A. H; Guinea, J.; Heussel, C.; Ibrahim, A. S; Kanj, S. S; Klimko, N.; Lackner, M.; Lamoth, F.; Lanternier, F.; Lass-Floerl, C.; Lee, D.; Lehrnbecher, T.; Lmimouni, B. E; Mares, M.; Maschmeyer, G.; Meis, J. F; Meletiadis, J.; Morrissey, C O.; Nucci, M.; Oladele, R.; Pagano, L.; Pasqualotto, A.; Patel, A.; Racil, Z.; Richardson, M.; Roilides, E.; Ruhnke, M.; Seyedmousavi, S.; Sidharthan, N.; Singh, N.; Sinko, J.; Skiada, A.; Slavin, M.; Soman, R.; Spellberg, B.; Steinbach, W.; Tan, B. H.; Ullmann, A. J; Vehreschild, J. J; Vehreschild, M. J G T; Walsh, T. J; White, P L.; Wiederhold, N. P; Zaoutis, T.; and Chakrabarti, A. The Lancet Infectious Diseases, 19(12): e405 – e421. 2019. Cited by: 1190; All Open Access, Green Open Access
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium [link]Paper   doi   link   bibtex  
Pharmacology of Liposomal Amphotericin B: An Introduction to Preclinical and Clinical Advances for Treatment of Life-threatening Invasive Fungal Infections. Walsh, T. J.; Lewis, R. E.; and Adler-Moore, J. Clinical Infectious Diseases, 68: S241 – S243. 2019. Cited by: 7; All Open Access, Green Open Access, Hybrid Gold Open Access
Pharmacology of Liposomal Amphotericin B: An Introduction to Preclinical and Clinical Advances for Treatment of Life-threatening Invasive Fungal Infections [link]Paper   doi   link   bibtex  
Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B. Groll, A. H; Rijnders, B. J. A.; Walsh, T. J.; Adler-Moore, J.; Lewis, R. E.; and Brüggemann, R. J. M. Clinical Infectious Diseases, 68: S260 – S274. 2019. Cited by: 104; All Open Access, Green Open Access, Hybrid Gold Open Access
Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B [link]Paper   doi   link   bibtex  
Corrigendum: Azole-resistance in aspergillus terreusand related species: An emerging problem or a rare phenomenon? (Frontiers in Microbiology (2018) 9 (516) DOI: 10.3389/fmicb.2018.00516). Zoran, T.; Sartori, B.; Sappl, L.; Aigner, M.; Sánchez-Reus, F.; Rezusta, A.; Chowdhary, A.; Taj-Aldeen, S. J.; Arendrup, M. C.; Oliveri, S.; Kontoyiannis, D. P.; Alastruey-Izquierdo, A.; Lagrou, K.; Lo Cascio, G.; Meis, J. F.; Buzina, W.; Farina, C.; Drogari-Apiranthitou, M.; Grancini, A.; Tortorano, A. M.; Willinger, B.; Hamprecht, A.; Johnson, E.; Klingspor, L.; Arsic-Arsenijevic, V.; Cornely, O. A.; Meletiadis, J.; Prammer, W.; Tullio, V.; Vehreschild, J.; Trovato, L.; Lewis, R. E.; Segal, E.; Rath, P.; Hamal, P.; Rodriguez-Iglesias, M.; Roilides, E.; Arikan-Akdagli, S.; Chakrabarti, A.; Colombo, A. L.; Fernández, M. S.; Martin-Gomez, M. T.; Badali, H.; Petrikkos, G.; Klimko, N.; Heimann, S. M.; Uzun, O.; Roudbary, M.; De La Fuente, S.; Houbraken, J.; Risslegger, B.; Sabino, R.; Lass-Flörl, C.; and Lackner, M. Frontiers in Microbiology, 10(JAN). 2019. Cited by: 2; All Open Access, Gold Open Access, Green Open Access
Corrigendum: Azole-resistance in aspergillus terreusand related species: An emerging problem or a rare phenomenon? (Frontiers in Microbiology (2018) 9 (516) DOI: 10.3389/fmicb.2018.00516) [link]Paper   doi   link   bibtex  
Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B. Adler-Moore, J.; Lewis, R. E.; Brüggemann, R. J. M.; Rijnders, B. J. A.; Groll, A. H.; and Walsh, T. J. Clinical Infectious Diseases, 68: S244 – S259. 2019. Cited by: 54; All Open Access, Green Open Access, Hybrid Gold Open Access
Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B [link]Paper   doi   link   bibtex  
Using state transition models to explore how the prevalence of subtherapeutic posaconazole exposures impacts the clinical utility of therapeutic drug monitoring for posaconazole tablets and oral suspension. Lewis, R. E.; Kontoyiannis, D. P.; Viale, P.; and Sarpong, E. M. Antimicrobial Agents and Chemotherapy, 63(12). 2019. Cited by: 12; All Open Access, Bronze Open Access, Green Open Access
Using state transition models to explore how the prevalence of subtherapeutic posaconazole exposures impacts the clinical utility of therapeutic drug monitoring for posaconazole tablets and oral suspension [link]Paper   doi   link   bibtex  
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: An observational multicenter study. Bartoletti, M.; Giannella, M.; Lewis, R. E.; Caraceni, P.; Tedeschi, S.; Paul, M.; Schramm, C.; Bruns, T.; Merli, M.; Cobos-Trigueros, N.; Seminari, E.; Retamar, P.; Muñoz, P.; Tumbarello, M.; Burra, P.; Cerenzia, M. T.; Barsic, B.; Calbo, E.; Maraolo, A. E.; Petrosillo, N.; Galan-Ladero, M. A.; D'Offizi, G.; Zak-Doron, Y.; Rodriguez-Baño, J.; Baldassarre, M.; Verucchi, G.; Domenicali, M.; Bernardi, M.; and Viale, P. Clinical Infectious Diseases, 69(10): 1731 – 1739. 2019. Cited by: 35; All Open Access, Green Open Access
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: An observational multicenter study [link]Paper   doi   link   bibtex  
ESCMID generic competencies in antimicrobial prescribing and stewardship: towards a European consensus. Dyar, O.; Beović, B.; Pulcini, C.; Tacconelli, E.; Hulscher, M.; Cookson, B.; Ashiru-Oredope, D.; Barcs, I.; Blix, H.; Buyle, F.; Chowers, M.; Čižman, M.; Del Pozo, J.; Deptula, A.; Dumpis, U.; Florea, D.; van de Garde, E.; Geffen, Y.; Giske, C.; Grau, S.; Hajdú, E.; Hell, M.; Hondo, Ł.; Hussein, K.; Huttner, B.; Kern, W.; Kernéis, S.; Knepper, V.; Kofteridis, D.; Kostyanev, T.; Kuijper, E.; Lebanova, H.; Lewis, R.; Cordina, C.; Matulionyte, R.; Maurer, F.; Messiaen, P.; Miciuleviciene, J.; Mrhar, A.; Nabuurs-Franssen, M.; Naesens, R.; Oxacelay, C.; Pagani, L.; Paño-Pardo, J.; Paul, M.; Petrikkos, G.; Pluess-Suard, C.; Popescu, G.; Porsche, U.; Prins, J.; Rello, J.; Rodríguez-Baño, J.; Rossolini, G.; Salzberger, B.; Seme, K.; Simonsen, G.; Sînziana, M.; Skovgaard, S.; Smith, I.; Sönsken, U.; Soriano, A.; Sviestiņa, I.; Szilagyi, E.; Tängdén, T.; Tattevin, P.; Tsioutis, C.; Vilde, A.; Wanke-Rytt, M.; Wechsler-Fördös, A.; and Zarb, P. Clinical Microbiology and Infection, 25(1): 13 – 19. 2019. Cited by: 43; All Open Access, Green Open Access, Hybrid Gold Open Access
ESCMID generic competencies in antimicrobial prescribing and stewardship: towards a European consensus [link]Paper   doi   link   bibtex  
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis. Lewis, R. E.; Wurster, S.; Beyda, N. D.; Albert, N. D.; and Kontoyiannis, D. P. Diagnostic Microbiology and Infectious Disease, 95(3). 2019. Cited by: 9
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis [link]Paper   doi   link   bibtex  
Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response. Welte, T.; Len, O.; Muñoz, P.; Romani, L.; Lewis, R.; and Perrella, A. Infection, 47(6): 919 – 927. 2019. Cited by: 17; All Open Access, Green Open Access, Hybrid Gold Open Access
Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response [link]Paper   doi   link   bibtex  
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study. Giannella, M.; Pascale, R.; Ferraro, G.; Toschi, A.; Pancaldi, L.; Furii, F.; Bartoletti, M.; Tedeschi, S.; Ambretti, S.; Lewis, R. E.; and Viale, P. International Journal of Antimicrobial Agents, 53(5): 574 – 581. 2019. Cited by: 3
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study [link]Paper   doi   link   bibtex  
Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model. Wurster, S.; Lewis, R. E.; Albert, N. D.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 63(2). 2019. Cited by: 14; All Open Access, Green Open Access
Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model [link]Paper   doi   link   bibtex  
Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies. Stanzani, M.; Vianelli, N.; Cavo, M.; Kontoyiannis, D. P.; and Lewis, R. E. Journal of Infection, 78(6): 484 – 490. 2019. Cited by: 20
Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies [link]Paper   doi   link   bibtex  
Live monitoring and analysis of fungal growth, viability, and mycelial morphology using the incucyte neurotrack processing module. Wurster, S.; Kumaresan, P. R.; Albert, N. D.; Hauser, P. J.; Lewis, R. E.; and Kontoyiannis, D. P. mBio, 10(3). 2019. Cited by: 20; All Open Access, Gold Open Access, Green Open Access
Live monitoring and analysis of fungal growth, viability, and mycelial morphology using the incucyte neurotrack processing module [link]Paper   doi   link   bibtex  
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections. Giannella, M.; Bussini, L.; Pascale, R.; Bartoletti, M.; Malagrinò, M.; Pancaldi, L.; Toschi, A.; Ferraro, G.; Marconi, L.; Ambretti, S.; Lewis, R.; and Viale, P. Open Forum Infectious Diseases, 6(12). 2019. Cited by: 37; All Open Access, Gold Open Access, Green Open Access
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections [link]Paper   doi   link   bibtex  
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study. Giannella, M.; Bartoletti, M.; Campoli, C.; Rinaldi, M.; Coladonato, S.; Pascale, R.; Tedeschi, S.; Ambretti, S.; Cristini, F.; Tumietto, F.; Siniscalchi, A.; Bertuzzo, V.; Morelli, M.; Cescon, M.; Pinna, A.; Lewis, R.; and Viale, P. Clinical Microbiology and Infection, 25(12): 1525 – 1531. 2019. Cited by: 47; All Open Access, Bronze Open Access
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study [link]Paper   doi   link   bibtex  
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature. Stanzani, M.; Cricca, M.; Sassi, C.; Sutto, E.; De Cicco, G.; Bonifazi, F.; Bertuzzi, C.; Bacci, F.; Paolini, S.; Cavo, M.; and Lewis, R. E. Mycoses, 62(12): 1100 – 1107. 2019. Cited by: 17
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature [link]Paper   doi   link   bibtex  
Beyond biomarkers: How enhanced CT imaging can improve the diagnostic-driven management of invasive mould disease. Stanzani, M.; Sassi, C.; Battista, G.; and Lewis, R. E. Medical Mycology, 57: S274 – S286. 2019. Cited by: 4
Beyond biomarkers: How enhanced CT imaging can improve the diagnostic-driven management of invasive mould disease [link]Paper   doi   link   bibtex  
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae. Gaibani, P.; Lombardo, D.; Bartoletti, M.; Ambretti, S.; Campoli, C.; Giannella, M.; Tedeschi, S.; Conti, M.; Mancini, R.; Landini, M. P.; Re, M. C.; Viale, P.; and Lewis, R. E. European Journal of Clinical Microbiology and Infectious Diseases, 38(10): 1925 – 1931. 2019. Cited by: 8
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae [link]Paper   doi   link   bibtex  
  2018 (20)
Clinical Approach to Infections in the Compromised Host. Shelburne, S. A.; Lewis, R. E.; and Kontoyiannis, D. P. 2018. Cited by: 0
Clinical Approach to Infections in the Compromised Host [link]Paper   doi   link   bibtex  
Development and applications of prognostic risk models in the management of invasive mold disease. Stanzani, M.; and Lewis, R. E. Journal of Fungi, 4(4). 2018. Cited by: 7; All Open Access, Gold Open Access, Green Open Access
Development and applications of prognostic risk models in the management of invasive mold disease [link]Paper   doi   link   bibtex  
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Ullmann, A.; Aguado, J.; Arikan-Akdagli, S.; Denning, D.; Groll, A.; Lagrou, K.; Lass-Flörl, C.; Lewis, R.; Munoz, P.; Verweij, P.; Warris, A.; Ader, F.; Akova, M.; Arendrup, M.; Barnes, R.; Beigelman-Aubry, C.; Blot, S.; Bouza, E.; Brüggemann, R.; Buchheidt, D.; Cadranel, J.; Castagnola, E.; Chakrabarti, A.; Cuenca-Estrella, M.; Dimopoulos, G.; Fortun, J.; Gangneux, J.; Garbino, J.; Heinz, W.; Herbrecht, R.; Heussel, C.; Kibbler, C.; Klimko, N.; Kullberg, B.; Lange, C.; Lehrnbecher, T.; Löffler, J.; Lortholary, O.; Maertens, J.; Marchetti, O.; Meis, J.; Pagano, L.; Ribaud, P.; Richardson, M.; Roilides, E.; Ruhnke, M.; Sanguinetti, M.; Sheppard, D.; Sinkó, J.; Skiada, A.; Vehreschild, M.; Viscoli, C.; and Cornely, O. Clinical Microbiology and Infection, 24: e1 – e38. 2018. Cited by: 1124; All Open Access, Bronze Open Access, Green Open Access
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline [link]Paper   doi   link   bibtex  
Preface. Johnson, A. P.; Lewis, R.; and Wickens, H. J. Journal of Antimicrobial Chemotherapy, 73: ii1. 2018. Cited by: 3; All Open Access, Bronze Open Access
Preface [link]Paper   doi   link   bibtex  
Overview of antifungal dosing in invasive candidiasis. Pea, F.; and Lewis, R. E. Journal of Antimicrobial Chemotherapy, 73: i33 – i43. 2018. Cited by: 34; All Open Access, Bronze Open Access
Overview of antifungal dosing in invasive candidiasis [link]Paper   doi   link   bibtex  
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Giannella, M.; Trecarichi, E. M.; Giacobbe, D. R.; De Rosa, F. G.; Bassetti, M.; Bartoloni, A.; Bartoletti, M.; Losito, A. R.; del Bono, V.; Corcione, S.; Tedeschi, S.; Raffaelli, F.; Saffioti, C.; Spanu, T.; Rossolini, G. M.; Marchese, A.; Ambretti, S.; Cauda, R.; Viscoli, C.; Lewis, R. E.; Viale, P.; and Tumbarello, M. International Journal of Antimicrobial Agents, 51(2): 244 – 248. 2018. Cited by: 64; All Open Access, Green Open Access
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection [link]Paper   doi   link   bibtex  
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients. Bartoletti, M.; Giannella, M.; Lewis, R.; Caraceni, P.; Tedeschi, S.; Paul, M.; Schramm, C.; Bruns, T.; Merli, M.; Cobos-Trigueros, N.; Seminari, E.; Retamar, P.; Muñoz, P.; Tumbarello, M.; Burra, P.; Torrani Cerenzia, M.; Barsic, B.; Calbo, E.; Maraolo, A.; Petrosillo, N.; Galan-Ladero, M.; D'Offizi, G.; Bar Sinai, N.; Rodríguez-Baño, J.; Verucchi, G.; Bernardi, M.; Viale, P.; Campoli, C.; Siccardi, G.; Ambretti, S.; Stallmach, A.; Venditti, M.; Lucidi, C.; Ludovisi, S.; De Cueto, M.; Navarro, M.; Lopez Cortes, E.; Bouza, E.; Valerio, M.; Eworo, A.; Losito, R.; Senzolo, M.; Nadal, E.; Ottobrelli, A.; Varguvic, M.; Badia, C.; Borgia, G.; Gentile, I.; Buonomo, A.; Boumis, E.; Beteta-Lopez, A.; Rianda, A.; Taliani, G.; and Grieco, S. Clinical Microbiology and Infection, 24(5): 546.e1 – 546.e8. 2018. Cited by: 80; All Open Access, Bronze Open Access
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients [link]Paper   doi   link   bibtex  
Acute Invasive Fungal Rhinosinusitis in Immunocompromised Patients: Role of an Early Diagnosis. Fernandez, I. J.; Crocetta, F. M.; Demattè, M.; Farneti, P.; Stanzani, M.; Lewis, R. E.; Fornaciari, M.; Pasquini, E.; and Sciarretta, V. Otolaryngology - Head and Neck Surgery (United States), 159(2): 386 – 393. 2018. Cited by: 28; All Open Access, Bronze Open Access
Acute Invasive Fungal Rhinosinusitis in Immunocompromised Patients: Role of an Early Diagnosis [link]Paper   doi   link   bibtex  
ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients. Cesaro, S.; Dalianis, T.; Rinaldo, C. H.; Koskenvuo, M.; Pegoraro, A.; Einsele, H.; Cordonnier, C.; Hirsch, H. H.; Akova, M.; Aljurf, M.; Averbuch, D.; Barnes, R.; Blennow, O.; Bochud, P.; Bouza, E.; Bretagne, S.; Brüggemann, R.; Calandra, T.; Carratala, J.; Cornely, O.; de la Camara, R.; Donnelly, P.; Drgona, L.; Duarte, R.; Engelhard, D.; Fox, C.; Girmenia, C.; Groll, A.; Heldal, D.; Helweg-Larsen, J.; Herbrecht, R.; Johnson, E.; Klyasova, G.; Lagrou, K.; Lewis, R. E.; Ljungman, P.; Maertens, J.; Mikulska, M.; Nucci, M.; Padoin, C.; Pagano, L.; Pagliuca, A.; Racil, Z.; Ribaud, P.; Rizzi-Puechal, V.; Roilides, E.; Robin, C.; Rovira, M.; Rupp, M.; Sanchez, S.; Schellongowski, P.; Sedlacek, P.; Sinko, J.; Slavin, M.; Ferreira, I. S.; Styczynski, J.; Tissot, F.; Viscoli, C.; Ward, K.; and Witschi, A. Journal of Antimicrobial Chemotherapy, 73(1): 12 – 21. 2018. Cited by: 148; All Open Access, Bronze Open Access
ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients [link]Paper   doi   link   bibtex  
Transcriptional profiles of pulmonary innate immune responses to isogenic antibiotic-susceptible and multidrug-resistant Pseudomonas aeruginosa. Tam, V. H.; Pérez, C.; Ledesma, K. R.; and Lewis, R. E. Microbiology and Immunology, 62(4): 291 – 294. 2018. Cited by: 8; All Open Access, Bronze Open Access
Transcriptional profiles of pulmonary innate immune responses to isogenic antibiotic-susceptible and multidrug-resistant Pseudomonas aeruginosa [link]Paper   doi   link   bibtex  
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections. Bartoletti, M.; Tedeschi, S.; Pascale, R.; Raumer, L.; Maraolo, A. E.; Palmiero, G.; Tumietto, F.; Cristini, F.; Ambretti, S.; Giannella, M.; Lewis, R. E.; and Viale, P. International Journal of Antimicrobial Agents, 51(3): 516 – 521. 2018. Cited by: 2
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections [link]Paper   doi   link   bibtex  
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: A pilot single-centre study. Giannella, M.; Paolucci, M.; Roncarati, G.; Vandi, G.; Pascale, R.; Trapani, F.; Bartoletti, M.; Tedeschi, S.; Ambretti, S.; Lewis, R.; Re, M. C.; and Viale, P. Journal of Antimicrobial Chemotherapy, 73(10): 2856 – 2859. 2018. Cited by: 13; All Open Access, Bronze Open Access
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: A pilot single-centre study [link]Paper   doi   link   bibtex  
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment. Gaibani, P.; Campoli, C.; Lewis, R. E.; Volpe, S. L.; Scaltriti, E.; Giannella, M.; Pongolini, S.; Berlingeri, A.; Cristini, F.; Bartoletti, M.; Tedeschi, S.; and Ambretti, S. Journal of Antimicrobial Chemotherapy, 73(6): 1525 – 1529. 2018. Cited by: 132; All Open Access, Bronze Open Access, Green Open Access
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment [link]Paper   doi   link   bibtex  
Breakthrough invasive mold infections in the hematology patient: Current concepts and future directions. Lionakis, M. S.; Lewis, R. E.; and Kontoyiannis, D. P. Clinical Infectious Diseases, 67(10): 1621 – 1630. 2018. Cited by: 133; All Open Access, Bronze Open Access, Green Open Access
Breakthrough invasive mold infections in the hematology patient: Current concepts and future directions [link]Paper   doi   link   bibtex  
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis. Bartoletti, M.; Lewis, R. E.; Giannella, M.; Tedeschi, S.; and Viale, P. Expert Review of Anti-Infective Therapy, 16(10): 771 – 779. 2018. Cited by: 4
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis [link]Paper   doi   link   bibtex  
The utility of contrast-enhanced hypodense sign for the diagnosis of pulmonary invasive mould disease in patients with haematological malignancies. Sassi, C.; Stanzani, M.; Lewis, R. E; Facchini, G.; Bazzocchi, A.; Cavo, M.; and Battista, G. British Journal of Radiology, 91(1083). 2018. Cited by: 13; All Open Access, Green Open Access
The utility of contrast-enhanced hypodense sign for the diagnosis of pulmonary invasive mould disease in patients with haematological malignancies [link]Paper   doi   link   bibtex  
Treatment duration for Escherichia coli bloodstream infection and outcomes: retrospective single-centre study. Giannella, M.; Pascale, R.; Toschi, A.; Ferraro, G.; Graziano, E.; Furii, F.; Bartoletti, M.; Tedeschi, S.; Ambretti, S.; Lewis, R.; and Viale, P. Clinical Microbiology and Infection, 24(10): 1077 – 1083. 2018. Cited by: 53; All Open Access, Bronze Open Access, Green Open Access
Treatment duration for Escherichia coli bloodstream infection and outcomes: retrospective single-centre study [link]Paper   doi   link   bibtex  
Azole-resistance in Aspergillus terreus and related species: An emerging problem or a rare Phenomenon?. Zoran, T.; Sartori, B.; Sappl, L.; Aigner, M.; Sánchez-Reus, F.; Rezusta, A.; Chowdhary, A.; Taj-Aldeen, S. J.; Arendrup, M. C.; Oliveri, S.; Kontoyiannis, D. P.; Alastruey-Izquierdo, A.; Lagrou, K.; Cascio, G. L.; Meis, J. F.; Buzina, W.; Farina, C.; Drogari-Apiranthitou, M.; Grancini, A.; Tortorano, A. M.; Willinger, B.; Hamprecht, A.; Johnson, E.; Klingspor, L.; Arsic-Arsenijevic, V.; Cornely, O. A.; Meletiadis, J.; Prammer, W.; Tullio, V.; Vehreschild, J.; Trovato, L.; Lewis, R. E.; Segal, E.; Rath, P.; Hamal, P.; Rodriguez-Iglesias, M.; Roilides, E.; Arikan-Akdagli, S.; Chakrabarti, A.; Colombo, A. L.; Fernández, M. S.; Martin-Gomez, M. T.; Badali, H.; Petrikkos, G.; Klimko, N.; Heimann, S. M.; Uzun, O.; Roudbary, M.; de la Fuente, S.; Houbraken, J.; Risslegger, B.; Lass-Flörl, C.; and Lackner, M. Frontiers in Microbiology, 9(MAR). 2018. Cited by: 66; All Open Access, Gold Open Access, Green Open Access
Azole-resistance in Aspergillus terreus and related species: An emerging problem or a rare Phenomenon? [link]Paper   doi   link   bibtex  
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia. Rizzello, I.; Castagnetti, F.; Toschi, P. G.; Bertaccini, P.; Primavera, L.; Paolucci, M.; Faccioli, L.; Spinardi, L.; Lewis, R. E.; Cavo, M.; and Stanzani, M. Mycoses, 61(1): 53 – 60. 2018. Cited by: 19
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia [link]Paper   doi   link   bibtex  
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines. Mikulska, M.; Tissot, F.; Cordonnier, C.; Akova, M.; Calandra, T.; Ceppi, M.; Bruzzi, P.; Viscoli, C.; Aljurf, M.; Averbuch, D.; Barnes, R.; Blennow, O.; Bochud, P.; Bouza, E.; Bretagne, S.; Brüggemann, R.; Carratala, J.; Cesaro, S.; Cornely, O.; Dalianis, T.; De La Camara, R.; Donnelly, P.; Drgona, L.; Duarte, R.; Einsele, H.; Engelhard, D.; Fox, C.; Girmenia, C.; Groll, A.; Heldal, D.; Larsen, J. H.; Herbrecht, R.; Hirsch, H.; Johnson, E.; Klyasova, G.; Koskuenvo, M.; Lagrou, K.; Lewis, R. E.; Ljungman, P.; Maertens, J.; Maschmeyer, G.; Nucci, M.; Padoin, C.; Pagano, L.; Pagliuca, A.; Racil, Z.; Ribaud, P.; Rinaldo, C.; Puechal, V. R.; Roilides, E.; Robin, C.; Rovira, M.; Rupp, M.; Sanchez, S.; Schellongowski, P.; Sedlacek, P.; Sinko, J.; Slavin, M.; Ferreira, I. S.; Styczynski, J.; Ward, K.; and Witschi, A. Journal of Infection, 76(1): 20 – 37. 2018. Cited by: 143
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines [link]Paper   doi   link   bibtex  
  2017 (15)
Retrospective cohort analysis of liposomal amphotericin b nephrotoxicity in patients with hematological malignancies. Stanzani, M.; Vianelli, N.; Cavo, M.; Maritati, A.; Morotti, M.; and Lewis, R. E. Antimicrobial Agents and Chemotherapy, 61(9). 2017. Cited by: 20; All Open Access, Green Open Access
Retrospective cohort analysis of liposomal amphotericin b nephrotoxicity in patients with hematological malignancies [link]Paper   doi   link   bibtex  
Characterization of antibody response in neuroinvasive infection caused by Toscana virus. Pierro, A.; Ficarelli, S.; Ayhan, N.; Morini, S.; Raumer, L.; Bartoletti, M.; Mastroianni, A.; Prati, F.; Schivazappa, S.; Cenni, P.; Vocale, C.; Rossini, G.; Gaibani, P.; Sambri, V.; Landini, M.; Lewis, R.; Charrel, R.; and Varani, S. Clinical Microbiology and Infection, 23(11): 868 – 873. 2017. Cited by: 20; All Open Access, Bronze Open Access
Characterization of antibody response in neuroinvasive infection caused by Toscana virus [link]Paper   doi   link   bibtex  
A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study. Risslegger, B.; Zoran, T.; Lackner, M.; Aigner, M.; Sánchez-Reus, F.; Rezusta, A.; Chowdhary, A.; Taj-Aldeen, S.; Arendrup, M.; Oliveri, S.; Kontoyiannis, D.; Alastruey-Izquierdo, A.; Lagrou, K.; Lo Cascio, G.; Meis, J.; Buzina, W.; Farina, C.; Drogari-Apiranthitou, M.; Grancini, A.; Tortorano, A.; Willinger, B.; Hamprecht, A.; Johnson, E.; Klingspor, L.; Arsic-Arsenijevic, V.; Cornely, O.; Meletiadis, J.; Prammer, W.; Tullio, V.; Vehreschild, J.; Trovato, L.; Lewis, R.; Segal, E.; Rath, P.; Hamal, P.; Rodriguez-Iglesias, M.; Roilides, E.; Arikan-Akdagli, S.; Chakrabarti, A.; Colombo, A.; Fernández, M.; Martin-Gomez, M.; Badali, H.; Petrikkos, G.; Klimko, N.; Heimann, S.; Houbraken, J.; Uzun, O.; Edlinger, M.; Fuente, S. d. l.; and Lass-Flörl, C. Clinical Microbiology and Infection, 23(10): 776.e1 – 776.e5. 2017. Cited by: 44; All Open Access, Bronze Open Access, Green Open Access
A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study [link]Paper   doi   link   bibtex  
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study. Giannella, M.; Graziano, E.; Marconi, L.; Girometti, N.; Bartoletti, M.; Tedeschi, S.; Tumietto, F.; Cristini, F.; Ambretti, S.; Berlingeri, A.; Lewis, R. E.; and Viale, P. European Journal of Clinical Microbiology and Infectious Diseases, 36(10): 1965 – 1970. 2017. Cited by: 19
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study [link]Paper   doi   link   bibtex  
Using carbapenems for carbapenem-resistant Klebsiella pneumoniae-Are we flogging a dead (work)horse antibiotic?. Lewis, R. E. Virulence, 8(1): 13 – 14. 2017. Cited by: 0; All Open Access, Gold Open Access, Green Open Access
Using carbapenems for carbapenem-resistant Klebsiella pneumoniae-Are we flogging a dead (work)horse antibiotic? [link]Paper   doi   link   bibtex  
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates. Gaibani, P.; Lewis, R. E.; Volpe, S. L.; Giannella, M.; Campoli, C.; Landini, M. P.; Viale, P.; Re, M. C.; and Ambretti, S. International Journal of Infectious Diseases, 65: 1 – 3. 2017. Cited by: 47; All Open Access, Gold Open Access, Green Open Access
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates [link]Paper   doi   link   bibtex  
Animal models for studying triazole resistance in aspergillus fumigatus. Lewis, R. E.; and Verweij, P. E Journal of Infectious Diseases, 216: S466 – S473. 2017. Cited by: 13; All Open Access, Bronze Open Access
Animal models for studying triazole resistance in aspergillus fumigatus [link]Paper   doi   link   bibtex  
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment. Bartoletti, M.; Martelli, G.; Tedeschi, S.; Morelli, M.; Bertuzzo, V.; Tadolini, M.; Pianta, P.; Cristini, F.; Giannella, M.; Lewis, R. E.; Pinna, A. D.; and Viale, P. Transplant Infectious Disease, 19(2). 2017. Cited by: 8
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment [link]Paper   doi   link   bibtex  
Radiologic findings of Fusarium pneumonia in neutropenic patients. Sassi, C.; Stanzani, M.; Lewis, R. E.; Vianelli, N.; Tarsi, A.; Poerio, A.; Cavo, M.; and Battista, G. Mycoses, 60(2): 73 – 78. 2017. Cited by: 17
Radiologic findings of Fusarium pneumonia in neutropenic patients [link]Paper   doi   link   bibtex  
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation with Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015. Heo, S. T.; Tatara, A. M.; Jiménez-Ortigosa, C.; Jiang, Y.; Lewis, R. E.; Tarrand, J.; Tverdek, F.; Albert, N. D.; Verweij, P. E.; Meis, J. F.; Mikos, A. G.; Perlin, D. S.; and Kontoyiannis, D. P. Clinical Infectious Diseases, 65(2): 216 – 225. 2017. Cited by: 52; All Open Access, Bronze Open Access, Green Open Access
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation with Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015 [link]Paper   doi   link   bibtex  
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients. Polverelli, N.; Breccia, M.; Benevolo, G.; Martino, B.; Tieghi, A.; Latagliata, R.; Sabattini, E.; Riminucci, M.; Godio, L.; Catani, L.; Nicolosi, M.; Perricone, M.; Sollazzo, D.; Colafigli, G.; Campana, A.; Merli, F.; Vitolo, U.; Alimena, G.; Martinelli, G.; Lewis, R. E.; Vianelli, N.; Cavo, M.; and Palandri, F. American Journal of Hematology, 92(1): 37 – 41. 2017. Cited by: 65; All Open Access, Bronze Open Access
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients [link]Paper   doi   link   bibtex  
Caspofungin. Lewis, R. E.; Beyda, N. D.; and Kontoyiannis, D. P. 2017. Cited by: 1
Caspofungin [link]Paper   doi   link   bibtex  
Micafungin. Beyda, N. D.; Lewis, R. E.; and Kontoyiannis, D. P. 2017. Cited by: 0
Micafungin [link]Paper   doi   link   bibtex  
Clinical Approach to Infections in the Compromised Host. Shelburne, S. A.; Lewis, R. E.; and Kontoyiannis, D. P. 2017. Cited by: 0
Clinical Approach to Infections in the Compromised Host [link]Paper   doi   link   bibtex  
Butenafine. Lewis, R. E.; Beyda, N. D.; and Kontoyiannis, D. P. 2017. Cited by: 0
Butenafine [link]Paper   doi   link   bibtex  
  2016 (9)
Preface. Gould, F. K.; Lewis, R. E.; and Richardson, M. D. Journal of Antimicrobial Chemotherapy, 71: ii1 – ii1. 2016. Cited by: 0; All Open Access, Bronze Open Access
Preface [link]Paper   doi   link   bibtex  
Improved Radiographic Imaging of Invasive Fungal Disease: The Cornerstone to Antifungal Stewardship in the Hematology Units?. Stanzani, M.; Sassi, C.; Battista, G.; Cavo, M.; and Lewis, R. E. Current Fungal Infection Reports, 10(2): 78 – 86. 2016. Cited by: 4
Improved Radiographic Imaging of Invasive Fungal Disease: The Cornerstone to Antifungal Stewardship in the Hematology Units? [link]Paper   doi   link   bibtex  
Antifungal prophylaxis in liver transplant recipients: one size does not fit all. Giannella, M.; Bartoletti, M.; Morelli, M.; Cristini, F.; Tedeschi, S.; Campoli, C.; Tumietto, F.; Bertuzzo, V.; Ercolani, G.; Faenza, S.; Pinna, A.; Lewis, R.; and Viale, P. Transplant Infectious Disease, 18(4): 538 – 544. 2016. Cited by: 34
Antifungal prophylaxis in liver transplant recipients: one size does not fit all [link]Paper   doi   link   bibtex  
Mucorales-specific T cells in patients with hematologic malignancies. Potenza, L.; Vallerini, D.; Barozzi, P.; Riva, G.; Gilioli, A.; Forghieri, F.; Candoni, A.; Cesaro, S.; Quadrelli, C.; Maertens, J.; Rossi, G.; Morselli, M.; Codeluppi, M.; Mussini, C.; Colaci, E.; Messerotti, A.; Paolini, A.; Maccaferri, M.; Fantuzzi, V.; Del Giovane, C.; Stefani, A.; Morandi, U.; Maffei, R.; Marasca, R.; Narni, F.; Fanin, R.; Comoli, P.; Romani, L.; Beauvais, A.; Viale, P. L.; Latgè, J. P.; Lewis, R. E.; and Luppi, M. PLoS ONE, 11(2). 2016. Cited by: 40; All Open Access, Gold Open Access, Green Open Access
Mucorales-specific T cells in patients with hematologic malignancies [link]Paper   doi   link   bibtex  
Statin Concentrations below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae. Bellanger, A.; Tatara, A. M.; Shirazi, F.; Gebremariam, T.; Albert, N. D.; Lewis, R. E.; Ibrahim, A. S.; and Kontoyiannis, D. P. Journal of Infectious Diseases, 214(1): 114 – 121. 2016. Cited by: 31; All Open Access, Bronze Open Access, Green Open Access
Statin Concentrations below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae [link]Paper   doi   link   bibtex  
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients. Curti, A.; Ruggeri, L.; Parisi, S.; Bontadini, A.; Dan, E.; Motta, M. R.; Rizzi, S.; Trabanelli, S.; Ocadlikova, D.; Lecciso, M.; Giudice, V.; Fruet, F.; Urbani, E.; Papayannidis, C.; Martinelli, G.; Bandini, G.; Bonifazi, F.; Lewis, R. E.; Cavo, M.; Velardi, A.; and Lemoli, R. M. Clinical Cancer Research, 22(8): 1914 – 1921. 2016. Cited by: 114; All Open Access, Green Open Access
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients [link]Paper   doi   link   bibtex  
Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis. Kyvernitakis, A.; Torres, H.; Jiang, Y.; Chamilos, G.; Lewis, R.; and Kontoyiannis, D. Clinical Microbiology and Infection, 22(9): 811.e1 – 811.e8. 2016. Cited by: 129; All Open Access, Bronze Open Access
Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis [link]Paper   doi   link   bibtex  
Bloodstream infections in patients with liver cirrhosis. Bartoletti, M.; Giannella, M.; Lewis, R. E.; and Viale, P. Virulence, 7(3): 309 – 319. 2016. Cited by: 75; All Open Access, Gold Open Access, Green Open Access
Bloodstream infections in patients with liver cirrhosis [link]Paper   doi   link   bibtex  
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. Maschmeyer, G.; Helweg-Larsen, J.; Pagano, L.; Robin, C.; Cordonnier, C.; Schellongowski, P.; Akova, M.; Aljurf, M.; Averbuch, D.; Barnes, R.; Blennow, O.; Bochud, P.; Bouza, E.; Bretagne, S.; Brüggemann, R.; Calandra, T.; Carratalà, J.; Cesaro, S.; Cornely, O.; Dalianis, T.; De La Camara, R.; Donnelly, P.; Drgona, L.; Duarte, R.; Einsele, H.; Engelhard, D.; Fox, C.; Girmenia, C.; Groll, A.; Heldal, D.; Helweg-Larsen, J.; Herbrecht, R.; Hirsch, H.; Johnson, E.; Klyasova, G.; Koskuenvo, M.; Lagrou, K.; Lewis, R. E.; Ljungman, P.; Maertens, J.; Mikulska, M.; Nucci, M.; Padoin, C.; Dwe, A.; Pagliuca, A.; Racil, Z.; Ribaud, P.; Rinaldo, C.; Rizzi-Puechal, V.; Roilides, E.; Rovira, M.; Rupp, M.; Sanchez, S.; Sedlacek, P.; Sinko, J.; Slavin, M.; Ferreira, I. S.; Styczynski, J.; Tissot, F.; Viscoli, C.; Ward, K.; and Witschi, A. Journal of Antimicrobial Chemotherapy, 71(9): 2405 – 2413. 2016. Cited by: 165; All Open Access, Bronze Open Access
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients [link]Paper   doi   link   bibtex  
  2015 (18)
Therapeutic drug monitoring of voriconazole. Lewis, R. E.; and Viale, P. 2015. Cited by: 0
Therapeutic drug monitoring of voriconazole [link]Paper   link   bibtex  
Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: The importance of pre- and posttransplant colonization. Giannella, M.; Bartoletti, M.; Morelli, M.; Tedeschi, S.; Cristini, F.; Tumietto, F.; Pasqualini, E.; Danese, I.; Campoli, C.; Lauria, N. D.; Faenza, S.; Ercolani, G.; Lewis, R.; Pinna, A.; and Viale, P. American Journal of Transplantation, 15(6): 1708 – 1715. 2015. Cited by: 104; All Open Access, Hybrid Gold Open Access
Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: The importance of pre- and posttransplant colonization [link]Paper   doi   link   bibtex  
Micafungin induced apoptosis in candida parapsilosis independent of its susceptibility to micafungin. Shirazi, F.; Lewis, R. E.; and Kontoyiannis, D. P. Microbial Cell, 2(11): 445 – 450. 2015. Cited by: 5; All Open Access, Gold Open Access, Green Open Access
Micafungin induced apoptosis in candida parapsilosis independent of its susceptibility to micafungin [link]Paper   doi   link   bibtex  
High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies. Stanzani, M.; Sassi, C.; Lewis, R. E.; Tolomelli, G.; Bazzocchi, A.; Cavo, M.; Vianelli, N.; and Battista, G. Clinical Infectious Diseases, 60(11): 1603 – 1610. 2015. Cited by: 81
High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies [link]Paper   doi   link   bibtex  
Drug interactions with voriconazole. Lewis, R. E.; and Viale, P. 2015. Cited by: 0
Drug interactions with voriconazole [link]Paper   link   bibtex  
Effect of preexposure to triazoles on susceptibility and virulence of Rhizopus oryzae. Bellanger, A.; Albert, N. D.; Lewis, R. E.; Walsh, T. J.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 59(12): 7830 – 7832. 2015. Cited by: 10; All Open Access, Bronze Open Access, Green Open Access
Effect of preexposure to triazoles on susceptibility and virulence of Rhizopus oryzae [link]Paper   doi   link   bibtex  
Voriconazole toxicology. Lewis, R. E.; and Viale, P. 2015. Cited by: 0
Voriconazole toxicology [link]Paper   link   bibtex  
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis. Viale, P.; Scudeller, L.; Pea, F.; Tedeschi, S.; Lewis, R.; Bartoletti, M.; Sbrojavacca, R.; Cristini, F.; Tumietto, F.; Di Lauria, N.; Fasulo, G.; and Giannella, M. Annals of Pharmacotherapy, 49(9): 978 – 985. 2015. Cited by: 14
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis [link]Paper   doi   link   bibtex  
Voriconazole treatment in invasive candidiasis. Viale, P.; and Lewis, R. E. 2015. Cited by: 0
Voriconazole treatment in invasive candidiasis [link]Paper   link   bibtex  
Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates. Beyda, N. D.; Liao, G.; Endres, B. T.; Lewis, R. E.; and Garey, K. W. Antimicrobial Agents and Chemotherapy, 59(9): 5405 – 5412. 2015. Cited by: 9; All Open Access, Bronze Open Access, Green Open Access
Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates [link]Paper   doi   link   bibtex  
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy. Viale, P.; Tumietto, F.; Giannella, M.; Bartoletti, M.; Tedeschi, S.; Ambretti, S.; Cristini, F.; Gibertoni, C.; Venturi, S.; Cavalli, M.; De Palma, A.; Puggioli, M.; Mosci, D.; Callea, E.; Masina, R.; Moro, M.; and Lewis, R. Clinical Microbiology and Infection, 21(3): 242 – 247. 2015. Cited by: 69; All Open Access, Bronze Open Access, Green Open Access
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy [link]Paper   doi   link   bibtex  
Computerized tomographic pulmonary angiography discriminates invasive mould disease of the lung from lymphoma. Sassi, C.; Stanzani, M.; and Lewis, R. E. British Journal of Haematology, 169(4): 462 – 462. 2015. Cited by: 2; All Open Access, Bronze Open Access
Computerized tomographic pulmonary angiography discriminates invasive mould disease of the lung from lymphoma [link]Paper   doi   link   bibtex  
Antifungal agents. Lewis, R. E.; and Fothergill, A. W. 2015. Cited by: 2
Antifungal agents [link]Paper   doi   link   bibtex  
High-dose weekly liposomal amphotericin B antifungal prophylaxis in patients undergoing liver transplantation: A prospective phase II trial. Giannella, M.; Ercolani, G.; Cristini, F.; Morelli, M.; Bartoletti, M.; Bertuzzo, V.; Tedeschi, S.; Faenza, S.; Puggioli, C.; Lewis, R. E.; Pinna, A. D.; and Viale, P. Transplantation, 99(4): 848 – 854. 2015. Cited by: 22; All Open Access, Bronze Open Access
High-dose weekly liposomal amphotericin B antifungal prophylaxis in patients undergoing liver transplantation: A prospective phase II trial [link]Paper   doi   link   bibtex  
Serum galactomannan diagnosis of breakthrough invasive fungal disease. Lewis, R. E.; Giannella, M.; and Viale, P. Clinical Infectious Diseases, 60(8): 1284. 2015. Cited by: 2; All Open Access, Bronze Open Access
Serum galactomannan diagnosis of breakthrough invasive fungal disease [link]Paper   doi   link   bibtex  
Treatment principles for the management of mold infections. Kontoyiannis, D. P.; and Lewis, R. E. Cold Spring Harbor Perspectives in Medicine, 5(4). 2015. Cited by: 26; All Open Access, Bronze Open Access, Green Open Access
Treatment principles for the management of mold infections [link]Paper   doi   link   bibtex  
Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians. Viale, P.; Giannella, M.; Tedeschi, S.; and Lewis, R. Current Opinion in Pharmacology, 24: 30 – 37. 2015. Cited by: 40
Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians [link]Paper   doi   link   bibtex  
Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae. Viale, P.; Giannella, M.; Bartoletti, M.; Tedeschi, S.; and Lewis, R. Infectious Diseases and Therapy, 4: 65 – 83. 2015. Cited by: 41; All Open Access, Gold Open Access, Green Open Access
Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae [link]Paper   doi   link   bibtex  
  2014 (14)
Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis. Lewis, R. E.; Albert, N. D.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 58(11): 6767 – 6772. 2014. Cited by: 45; All Open Access, Bronze Open Access, Green Open Access
Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis [link]Paper   doi   link   bibtex  
Klebsiella pneumoniae bloodstream infection epidemiology and impact of inappropriate empirical therapy. Girometti, N.; Lewis, R. E.; Giannella, M.; Ambretti, S.; Bartoletti, M.; Tedeschi, S.; Tumietto, F.; Cristini, F.; Trapani, F.; Gaibani, P.; and Viale, P. Medicine (United States), 93(17): 298 – 308. 2014. Cited by: 104; All Open Access, Gold Open Access, Green Open Access
Klebsiella pneumoniae bloodstream infection epidemiology and impact of inappropriate empirical therapy [link]Paper   doi   link   bibtex  
Reply to "Risk for invasive fungal infections during acute myeloid leukemia induction therapy: A true association with echinocandins?". Kontoyiannis, D. P.; and Lewis, R. E. Antimicrobial Agents and Chemotherapy, 58(8): 4990 – 4991. 2014. Cited by: 0; All Open Access, Bronze Open Access, Green Open Access
Reply to "Risk for invasive fungal infections during acute myeloid leukemia induction therapy: A true association with echinocandins?" [link]Paper   doi   link   bibtex  
Agents of Mucormycosis and Entomophthoramycosis. Kontoyiannis, D. P.; and Lewis, R. E. Volume 2 2014. Cited by: 22
Agents of Mucormycosis and Entomophthoramycosis [link]Paper   doi   link   bibtex  
Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: Relevance of concomitant systemic antibiotic therapy. Tascini, C.; Sbrana, F.; Flammini, S.; Tagliaferri, E.; Arena, F.; Leonildi, A.; Ciullo, I.; Amadori, F.; Di Paolo, A.; Ripoli, A.; Lewis, R.; Rossolini, G. M.; Menichetti, F.; Lambelet, P.; Forfori, F.; Viaggi, B.; Papini, F.; Urbani, L.; and Malacarne, P. Antimicrobial Agents and Chemotherapy, 58(4): 1972 – 1976. 2014. Cited by: 61; All Open Access, Bronze Open Access, Green Open Access
Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: Relevance of concomitant systemic antibiotic therapy [link]Paper   doi   link   bibtex  
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011. Gomes, M. Z. R.; Mulanovich, V. E.; Jiang, Y.; Lewis, R. E.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 58(2): 865 – 873. 2014. Cited by: 46; All Open Access, Bronze Open Access, Green Open Access
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011 [link]Paper   doi   link   bibtex  
Macrophage reporter cell assay for screening immunopharmacological activity of cell wall-active antifungals. Lewis, R. E.; Liao, G.; Young, K.; Douglas, C.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 58(3): 1738 – 1743. 2014. Cited by: 15; All Open Access, Bronze Open Access, Green Open Access
Macrophage reporter cell assay for screening immunopharmacological activity of cell wall-active antifungals [link]Paper   doi   link   bibtex  
Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-Susceptible candida parapsilosis isolates with different degrees of caspofungin susceptibility. Dimopoulou, D.; Hamilos, G.; Tzardi, M.; Lewis, R. E.; Samonis, G.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 58(1): 229 – 236. 2014. Cited by: 11; All Open Access, Bronze Open Access, Green Open Access
Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-Susceptible candida parapsilosis isolates with different degrees of caspofungin susceptibility [link]Paper   doi   link   bibtex  
Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia. Gomes, M. Z.; Jiang, Y.; Mulanovich, V. E.; Lewis, R. E.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 58(5): 2775 – 2780. 2014. Cited by: 37; All Open Access, Bronze Open Access, Green Open Access
Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia [link]Paper   doi   link   bibtex  
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study. Giannella, M.; Trecarichi, E.; De Rosa, F.; Del Bono, V.; Bassetti, M.; Lewis, R.; Losito, A.; Corcione, S.; Saffioti, C.; Bartoletti, M.; Maiuro, G.; Cardellino, C.; Tedeschi, S.; Cauda, R.; Viscoli, C.; Viale, P.; and Tumbarello, M. Clinical Microbiology and Infection, 20(12): 1357 – 1362. 2014. Cited by: 210; All Open Access, Bronze Open Access
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study [link]Paper   doi   link   bibtex  
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation: A management challenge. Giannella, M.; Morelli, M. C.; Cristini, F.; Ercolani, G.; Cescon, M.; Bartoletti, M.; Tedeschi, S.; Pasqualini, E.; Lewis, R. E.; Pinna, A. D.; and Viale, P. Liver Transplantation, 20(5): 631 – 633. 2014. Cited by: 8; All Open Access, Bronze Open Access
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation: A management challenge [link]Paper   doi   link   bibtex  
In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates. Gaibani, P.; Lombardo, D.; Lewis, R. E.; Mercuri, M.; Bonora, S.; Landini, M. P.; and Ambretti, S. Journal of Antimicrobial Chemotherapy, 69(7): 1856 – 1865. 2014. Cited by: 74; All Open Access, Bronze Open Access
In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates [link]Paper   doi   link   bibtex  
Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis. Lewis, R. E.; Georgiadou, S. P.; Sampsonas, F.; Chamilos, G.; and Kontoyiannis, D. P. Mycoses, 57(1): 49 – 55. 2014. Cited by: 32; All Open Access, Green Open Access
Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis [link]Paper   doi   link   bibtex  
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. Bartoletti, M.; Giannella, M.; Caraceni, P.; Domenicali, M.; Ambretti, S.; Tedeschi, S.; Verucchi, G.; Badia, L.; Lewis, R. E.; Bernardi, M.; and Viale, P. Journal of Hepatology, 61(1): 51 – 58. 2014. Cited by: 113
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis [link]Paper   doi   link   bibtex  
  2013 (16)
A Risk Prediction Score for Invasive Mold Disease in Patients with Hematological Malignancies. Stanzani, M.; Lewis, R. E.; Fiacchini, M.; Ricci, P.; Tumietto, F.; Viale, P.; Ambretti, S.; Baccarani, M.; Cavo, M.; and Vianelli, N. PLoS ONE, 8(9). 2013. Cited by: 54; All Open Access, Gold Open Access, Green Open Access
A Risk Prediction Score for Invasive Mold Disease in Patients with Hematological Malignancies [link]Paper   doi   link   bibtex  
Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis. Lewis, R. E.; Ben-Ami, R.; Best, L.; Albert, N.; Walsh, T. J.; and Kontoyiannis, D. P. Journal of Infectious Diseases, 207(5): 834 – 841. 2013. Cited by: 59; All Open Access, Bronze Open Access, Green Open Access
Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis [link]Paper   doi   link   bibtex  
The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis. Georgiadou, S.; Lewis, R.; Best, L.; Torres, H.; Champlin, R.; and Kontoyiannis, D. Bone Marrow Transplantation, 48(1): 141 – 143. 2013. Cited by: 13
The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis [link]Paper   doi   link   bibtex  
Epidemiology and treatment of mucormycosis. Lewis, R. E; and Kontoyiannis, D. P Future Microbiology, 8(9): 1163 – 1175. 2013. Cited by: 86
Epidemiology and treatment of mucormycosis [link]Paper   doi   link   bibtex  
Treatment of carbapenem-resistant Klebsiella pneumoniae: The state of the art. Petrosillo, N.; Giannella, M.; Lewis, R.; and Viale, P. Expert Review of Anti-Infective Therapy, 11(2): 159 – 177. 2013. Cited by: 155
Treatment of carbapenem-resistant Klebsiella pneumoniae: The state of the art [link]Paper   doi   link   bibtex  
Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia. Kontoyiannis, D. P.; Georgiadou, S. P.; Wierda, W. G.; Wright, S.; Albert, N. D.; Ferrajoli, A.; Keating, M.; and Lewis, R. E. Leukemia and Lymphoma, 54(8): 1730 – 1733. 2013. Cited by: 33; All Open Access, Green Open Access
Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia [link]Paper   doi   link   bibtex  
Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections. Viale, P.; Giannella, M.; Lewis, R.; Trecarichi, E. M.; Petrosillo, N.; and Tumbarello, M. Expert Review of Anti-Infective Therapy, 11(10): 1053 – 1063. 2013. Cited by: 82
Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections [link]Paper   doi   link   bibtex  
Immunomodulatory agents as adjunctive therapy for the treatment of resistant Candida species. Beyda, N. D.; Regen, S.; Lewis, R. E.; and Garey, K. W. Current Fungal Infection Reports, 7(2): 119 – 125. 2013. Cited by: 1
Immunomodulatory agents as adjunctive therapy for the treatment of resistant Candida species [link]Paper   doi   link   bibtex  
High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia. Lewis, R. E.; Albert, N. P.; Liao, G.; Wang, W.; Prince, R. A.; and Kontoyiannis, D. P. Journal of Antimicrobial Chemotherapy, 68(5): 1148 – 1151. 2013. Cited by: 9; All Open Access, Bronze Open Access
High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia [link]Paper   doi   link   bibtex  
Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis. Ben-Ami, R.; Albert, N. D.; Lewis, R. E.; and Kontoyiannis, D. P. Journal of Infectious Diseases, 207(7): 1066 – 1074. 2013. Cited by: 22; All Open Access, Bronze Open Access, Green Open Access
Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis [link]Paper   doi   link   bibtex  
Synergistic activity of colistin plus rifampin against colistin-resistant kpc-producing klebsiella pneumoniae. Tascini, C.; Tagliaferri, E.; Giani, T.; Leonildi, A.; Flammini, S.; Casini, B.; Lewis, R.; Ferranti, S.; Rossolini, G. M.; and Menichetti, F. Antimicrobial Agents and Chemotherapy, 57(8): 3990 – 3993. 2013. Cited by: 111; All Open Access, Bronze Open Access, Green Open Access
Synergistic activity of colistin plus rifampin against colistin-resistant kpc-producing klebsiella pneumoniae [link]Paper   doi   link   bibtex  
Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients. Paolucci, M.; Stanzani, M.; Melchionda, F.; Tolomelli, G.; Castellani, G.; Landini, M. P.; Varani, S.; Lewis, R. E.; and Sambri, V. Diagnostic Microbiology and Infectious Disease, 75(2): 130 – 134. 2013. Cited by: 36
Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients [link]Paper   doi   link   bibtex  
Drosophila melanogaster as a model to explore the effects of methicillin-resistant Staphylococcus aureus strain type on virulence and response to linezolid treatment. Ben-Ami, R.; Watson, C. C.; Lewis, R. E.; Albert, N. D.; Arias, C. A.; Raad, I. I.; and Kontoyiannis, D. P. Microbial Pathogenesis, 55(1): 16 – 20. 2013. Cited by: 11
Drosophila melanogaster as a model to explore the effects of methicillin-resistant Staphylococcus aureus strain type on virulence and response to linezolid treatment [link]Paper   doi   link   bibtex  
Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: A 20-year autopsy study. Lewis, R. E.; Cahyame-Zuniga, L.; Leventakos, K.; Chamilos, G.; Ben-Ami, R.; Tamboli, P.; Tarrand, J.; Bodey, G. P.; Luna, M.; and Kontoyiannis, D. P. Mycoses, 56(6): 638 – 645. 2013. Cited by: 215
Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: A 20-year autopsy study [link]Paper   doi   link   bibtex  
Hyperthermia sensitizes rhizopus oryzae to posaconazole and itraconazole action through apoptosis. Shirazi, F.; Pontikos, M. A.; Walsh, T. J.; Albert, N.; Lewis, R. E.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 57(9): 4360 – 4368. 2013. Cited by: 19; All Open Access, Bronze Open Access, Green Open Access
Hyperthermia sensitizes rhizopus oryzae to posaconazole and itraconazole action through apoptosis [link]Paper   doi   link   bibtex  
Aggressive versus conservative initiation of antibiotics. Girardis, M.; Bassetti, M.; Lewis, R. E; and Viale, P. The Lancet Infectious Diseases, 13(5): 387. 2013. Cited by: 0; All Open Access, Bronze Open Access
Aggressive versus conservative initiation of antibiotics [link]Paper   doi   link   bibtex  
  2012 (14)
Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies. Cahuayme-Zuniga, L.; Lewis, R. E.; Mulanovich, V. E.; and Kontoyiannis, D. P. Medical Mycology, 50(5): 543 – 548. 2012. Cited by: 15; All Open Access, Bronze Open Access, Green Open Access
Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies [link]Paper   doi   link   bibtex  
Invasive mold infections in pediatric cancer patients reflect heterogeneity in etiology, presentation, and outcome: A 10-year, single-institution, retrospective study. Georgiadou, S. P.; Pongas, G.; Fitzgerald, N. E.; Lewis, R. E.; Rytting, M.; Marom, E. M.; and Kontoyiannis, D. P. Journal of the Pediatric Infectious Diseases Society, 1(2): 125 – 135. 2012. Cited by: 28; All Open Access, Bronze Open Access
Invasive mold infections in pediatric cancer patients reflect heterogeneity in etiology, presentation, and outcome: A 10-year, single-institution, retrospective study [link]Paper   doi   link   bibtex  
Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. Chitasombat, M. N.; Kofteridis, D. P.; Jiang, Y.; Tarrand, J.; Lewis, R. E.; and Kontoyiannis, D. P. Journal of Infection, 64(1): 68 – 75. 2012. Cited by: 120; All Open Access, Green Open Access
Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer [link]Paper   doi   link   bibtex  
Importance of pharmacokinetic considerations for selecting therapy in the treatment of invasive fungal infections. Lewis, R. E. American Journal of Therapeutics, 19(1): 51 – 63. 2012. Cited by: 9
Importance of pharmacokinetic considerations for selecting therapy in the treatment of invasive fungal infections [link]Paper   doi   link   bibtex  
Future directions in mucormycosis research. Kontoyiannis, D. P.; Lewis, R. E.; Lotholary, O.; Spellberg, B.; Petrikkos, G.; Roillides, E.; Ibrahim, A.; and Walsh, T. J. Clinical Infectious Diseases, 54(SUPPL. 1): S79–S85. 2012. Cited by: 36; All Open Access, Green Open Access
Future directions in mucormycosis research [link]Paper   doi   link   bibtex  
Update on amphotericin B pharmacology and dosing for common systemic mycoses. Lewis, R. E.; and Viale, P. Current Fungal Infection Reports, 6(4): 349 – 357. 2012. Cited by: 2
Update on amphotericin B pharmacology and dosing for common systemic mycoses [link]Paper   doi   link   bibtex  
Interactions of liposome carriers with infectious fungal hyphae reveals the role of β-glucans. Chavan, N. L.; Young, J. K.; Drezek, R. A.; Lewis, R.; and Bikram, M. Molecular Pharmaceutics, 9(9): 2489 – 2496. 2012. Cited by: 9
Interactions of liposome carriers with infectious fungal hyphae reveals the role of β-glucans [link]Paper   doi   link   bibtex  
Defining the role of echinocandin catechol functional groups in the development of secondary hepatocellular carcinoma. Julius, J. M.; Gaikwad, A.; Lowry, A.; Lewis, R. E.; Lozano, R. D.; Dalrymple, J. L.; Coleman, R. L.; and Smith, J. A. Journal of Antimicrobial Chemotherapy, 67(2): 422 – 429. 2012. Cited by: 5; All Open Access, Bronze Open Access
Defining the role of echinocandin catechol functional groups in the development of secondary hepatocellular carcinoma [link]Paper   doi   link   bibtex  
The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida. Lewis, R. E.; Viale, P.; and Kontoyiannis, D. P. Virulence, 3(4): 368 – 376. 2012. Cited by: 41; All Open Access, Gold Open Access, Green Open Access
The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida [link]Paper   doi   link   bibtex  
Echinocandin resistance in Candida species: Mechanisms of reduced susceptibility and therapeutic approaches; [Resistencia a equinocandinas en especies de candida: Mecanismos de susceptibilidad reducida y alternativas terapéuticas]. Beyda, N. D.; Lewis, R. E.; and Garey, K. W. Annals of Pharmacotherapy, 46(7-8): 1086 – 1096. 2012. Cited by: 99
Echinocandin resistance in Candida species: Mechanisms of reduced susceptibility and therapeutic approaches; [Resistencia a equinocandinas en especies de candida: Mecanismos de susceptibilidad reducida y alternativas terapéuticas] [link]Paper   doi   link   bibtex  
Mouse models for the study of fungal pneumonia: A collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus. Muhammed, M.; Feldmesser, M.; Shubitz, L. F.; Lionakis, M. S.; Sil, A.; Wang, Y.; Glavis-Blom, J.; Lewis, R. E.; Galgiani, J.; Casadevall, A.; Kontoyiannis, D. P.; and Mylonakis, E. Virulence, 3(3): 15. 2012. Cited by: 14
Mouse models for the study of fungal pneumonia: A collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus [link]Paper   link   bibtex  
Combination therapy for mucormycosis: Why, what, and how?. Spellberg, B.; Ibrahim, A.; Roilides, E.; Lewis, R. E.; Lortholary, O.; Petrikkos, G.; Kontoyiannis, D. P.; and Walsh, T. J. Clinical Infectious Diseases, 54(SUPPL. 1): S73–S78. 2012. Cited by: 146; All Open Access, Green Open Access, Hybrid Gold Open Access
Combination therapy for mucormycosis: Why, what, and how? [link]Paper   doi   link   bibtex  
Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies. Stanzani, M.; Battista, G.; Sassi, C.; Lewis, R. E.; Tolomelli, G.; Clissa, C.; Femia, R.; Bazzocchi, A.; Tumietto, F.; Viale, P.; Ambretti, S.; Baccarani, M.; and Vianelli, N. Clinical Infectious Diseases, 54(5): 610 – 616. 2012. Cited by: 55; All Open Access, Bronze Open Access, Green Open Access
Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies [link]Paper   doi   link   bibtex  
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?. Lewis, R. E.; Lortholary, O.; Spellberg, B.; Roilides, E.; Kontoyiannis, D. P.; and Walsh, T. J. Clinical Infectious Diseases, 54(SUPPL. 1): S67–S72. 2012. Cited by: 52; All Open Access, Bronze Open Access, Green Open Access
How does antifungal pharmacology differ for mucormycosis versus aspergillosis? [link]Paper   doi   link   bibtex  
  2011 (12)
Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Gomes, M. Z. R.; Lewis, R. E.; and Kontoyiannis, D. P. Clinical Microbiology Reviews, 24(2): 411 – 445. 2011. Cited by: 329; All Open Access, Green Open Access
Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species [link]Paper   doi   link   bibtex  
Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance. Ben-Ami, R.; Garcia-Effron, G.; Lewis, R. E.; Gamarra, S.; Leventakos, K.; Perlin, D. S.; and Kontoyiannis, D. P. Journal of Infectious Diseases, 204(4): 626 – 635. 2011. Cited by: 129; All Open Access, Bronze Open Access, Green Open Access
Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance [link]Paper   doi   link   bibtex  
Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosis. Lewis, R. E.; Leventakos, K.; Liao, G.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 55(7): 3584 – 3587. 2011. Cited by: 13; All Open Access, Green Open Access
Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosis [link]Paper   doi   link   bibtex  
Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus. Lewis, R. E.; Liao, G.; Hou, J.; Prince, R. A.; and Kontoyiannis, D. P. Journal of Antimicrobial Chemotherapy, 66(6): 1324 – 1331. 2011. Cited by: 16
Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus [link]Paper   doi   link   bibtex  
Activity of deferasirox in Mucorales: Influences of species and exogenous iron. Lewis, R. E.; Pongas, G. N.; Albert, N.; Ben-Ami, R.; Walsh, T. J.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 55(1): 411 – 413. 2011. Cited by: 25; All Open Access, Green Open Access
Activity of deferasirox in Mucorales: Influences of species and exogenous iron [link]Paper   doi   link   bibtex  
Pharmacokinetic-pharmacodynamic optimization of triazole antifungal therapy. Lewis, R. E. Current Opinion in Infectious Diseases, 24(SUPPL. 2): S14–S29. 2011. Cited by: 14; All Open Access, Bronze Open Access
Pharmacokinetic-pharmacodynamic optimization of triazole antifungal therapy [link]Paper   doi   link   bibtex  
Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species. Chen, S. C.; Lewis, R. E.; and Kontoyiannis, D. P. Virulence, 2(4). 2011. Cited by: 29; All Open Access, Gold Open Access, Green Open Access
Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species [link]Paper   doi   link   bibtex  
Current concepts in antifungal pharmacology. Lewis, R. E. Mayo Clinic Proceedings, 86(8): 805 – 817. 2011. Cited by: 313; All Open Access, Bronze Open Access, Green Open Access
Current concepts in antifungal pharmacology [link]Paper   doi   link   bibtex  
In vitro interactions among echinocandins against Aspergillus fumigatus: Lack of concordance among methods. Ben-Ami, R.; Lewis, R. E.; and Kontoyiannis, D. P. Medical Mycology, 49(3): 285 – 288. 2011. Cited by: 9; All Open Access, Bronze Open Access
In vitro interactions among echinocandins against Aspergillus fumigatus: Lack of concordance among methods [link]Paper   doi   link   bibtex  
How I treat mucormycosis. Kontoyiannis, D. P.; and Lewis, R. E. Blood, 118(5): 1216 – 1224. 2011. Cited by: 302; All Open Access, Bronze Open Access, Green Open Access
How I treat mucormycosis [link]Paper   doi   link   bibtex  
Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection. Lewis, R. E.; Liao, G.; Wang, W.; Prince, R. A.; and Kontoyiannis, D. P. Virulence, 2(4): 348 – 355. 2011. Cited by: 41; All Open Access, Gold Open Access
Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection [link]Paper   doi   link   bibtex  
Cutaneous mucormycosis in tornado survivors. Lewis, R. E. Current Fungal Infection Reports, 5(4): 187 – 189. 2011. Cited by: 3
Cutaneous mucormycosis in tornado survivors [link]Paper   doi   link   bibtex  
  2010 (16)
Exploring the concordance of aspergillus fumigatus pathogenicity in mice and Toll-deficient flies. Chamilos, G.; Bignell, E. M.; Schrettl, M.; Lewis, R. E.; Leventakos, K.; May, G. S.; Haas, H.; and Kontoyiannis, D. P. Medical Mycology, 48(3): 506 – 510. 2010. Cited by: 29; All Open Access, Bronze Open Access
Exploring the concordance of aspergillus fumigatus pathogenicity in mice and Toll-deficient flies [link]Paper   doi   link   bibtex  
Lack of galactomannan reactivity in dematiaceous molds recovered from cancer patients with phaeohyphomycosis. Ben-Ami, R.; LaSala, P. R.; Lewis, R. E.; and Kontoyiannis, D. P. Diagnostic Microbiology and Infectious Disease, 66(2): 200 – 203. 2010. Cited by: 12
Lack of galactomannan reactivity in dematiaceous molds recovered from cancer patients with phaeohyphomycosis [link]Paper   doi   link   bibtex  
Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. Campo, M.; Lewis, R. E.; and Kontoyiannis, D. P. Journal of Infection, 60(5): 331 – 337. 2010. Cited by: 161
Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009 [link]Paper   doi   link   bibtex  
Fungal infections in leukemia patients: How do we prevent and treat them?. Leventakos, K.; Lewis, R. E.; and Kontoyiannis, D. P. Clinical Infectious Diseases, 50(3): 405 – 415. 2010. Cited by: 134; All Open Access, Bronze Open Access
Fungal infections in leukemia patients: How do we prevent and treat them? [link]Paper   doi   link   bibtex  
Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis. Lewis, R. E.; Albert, N. D.; Liao, G.; Hou, J.; Prince, R. A.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 54(3): 1298 – 1304. 2010. Cited by: 70; All Open Access, Green Open Access
Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis [link]Paper   doi   link   bibtex  
Studying Fungal Pathogenesis in Drosophila. Kontoyiannis, D. P.; and Lewis, R. E. Microbe, 5(7): 291 – 296. 2010. Cited by: 5
Studying Fungal Pathogenesis in Drosophila [link]Paper   doi   link   bibtex  
Polyene antifungal agents. Lewis, R. E. 2010. Cited by: 4
Polyene antifungal agents [link]Paper   doi   link   bibtex  
Cutaneous model of invasive aspergillosis. Ben-Ami, R.; Lewis, R. E.; Leventakos, K.; Latgé, J.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 54(5): 1848 – 1854. 2010. Cited by: 32; All Open Access, Green Open Access
Cutaneous model of invasive aspergillosis [link]Paper   doi   link   bibtex  
Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis. Milito, M. A.; Kontoyiannis, D. P.; Lewis, R. E.; Liu, P.; Mawlawi, O. R.; Truong, M. T.; and Marom, E. M. Medical Mycology, 48(6): 817 – 823. 2010. Cited by: 39; All Open Access, Bronze Open Access
Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis [link]Paper   doi   link   bibtex  
Enemy of the (immunosuppressed) state: An update on the pathogenesis of Aspergillus fumigatus infection. Ben-Ami, R.; Lewis, R. E.; and Kontoyiannis, D. P. British Journal of Haematology, 150(4): 406 – 417. 2010. Cited by: 104; All Open Access, Bronze Open Access
Enemy of the (immunosuppressed) state: An update on the pathogenesis of Aspergillus fumigatus infection [link]Paper   doi   link   bibtex  
Antifungal therapeutic drug monitoring. Lewis, R. E. Current Fungal Infection Reports, 4(3): 158 – 167. 2010. Cited by: 22
Antifungal therapeutic drug monitoring [link]Paper   doi   link   bibtex  
Toll-deficient Drosophila are resistant to infection by Pneumocystis spp. additional evidence of specificity to mammalian hosts. Evans, S. E.; Leventakos, K.; Ben-Ami, R.; You, D.; Thakkar, S. G.; Lewis, R. E.; and Kontoyiannis, D. P. Virulence, 1(6): 523 – 525. 2010. Cited by: 6; All Open Access, Gold Open Access
Toll-deficient Drosophila are resistant to infection by Pneumocystis spp. additional evidence of specificity to mammalian hosts [link]Paper   doi   link   bibtex  
Characterization of a 5-azacytidine-induced developmental Aspergillus fumigatus variant. Ben-Ami, R.; Varga, J.; Lewis, R. E.; May, G. S.; Nierman, W. C.; and Kontoyiannis, D. P. Virulence, 1(3): 164 – 173. 2010. Cited by: 16; All Open Access, Gold Open Access, Green Open Access
Characterization of a 5-azacytidine-induced developmental Aspergillus fumigatus variant [link]Paper   doi   link   bibtex  
Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. Evans, S. E.; Scott, B. L.; Clement, C. G.; Larson, D. T.; Kontoyiannis, D.; Lewis, R. E.; Lasala, P. R.; Pawlik, J.; Peterson, J. W.; Chopra, A. K.; Klimpel, G.; Bowden, G.; Höök, M.; Xu, Y.; Tuvim, M. J.; and Dickey, B. F. American Journal of Respiratory Cell and Molecular Biology, 42(1): 40 – 50. 2010. Cited by: 93; All Open Access, Green Open Access
Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi [link]Paper   doi   link   bibtex  
Antifungal activity of colistin against Mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection. Ben-Ami, R.; Lewis, R. E.; Tarrand, J.; Leventakos, K.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 54(1): 484 – 490. 2010. Cited by: 58; All Open Access, Green Open Access
Antifungal activity of colistin against Mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection [link]Paper   doi   link   bibtex  
Interstrain variability in the virulence of Aspergillus fumigatus and Aspergillus terreus in a Toll-deficient Drosophila fly model of invasive aspergillosis. Ben-Ami, R.; Lamaris, G. A.; Lewis, R. E.; and Kontoyiannis, D. P. Medical Mycology, 48(2): 310 – 317. 2010. Cited by: 32
Interstrain variability in the virulence of Aspergillus fumigatus and Aspergillus terreus in a Toll-deficient Drosophila fly model of invasive aspergillosis [link]Paper   doi   link   bibtex  
  2009 (19)
Candida albicans Cas5, a regulator of cell wall integrity, is required for virulence in murine and toll mutant fly models. Chamilos, G.; Nobile, C. J.; Bruno, V. M.; Lewis, R. E.; Mitchell, A. P.; and Kontoyiannis, D. P. Journal of Infectious Diseases, 200(1): 152 – 157. 2009. Cited by: 48; All Open Access, Bronze Open Access, Green Open Access
Candida albicans Cas5, a regulator of cell wall integrity, is required for virulence in murine and toll mutant fly models [link]Paper   doi   link   bibtex  
Immunomodulating effects of antifungal therapy. Leventakos, K.; Ben-Ami, R.; Lewis, R. E.; and Kontoyiannis, D. P. Current Fungal Infection Reports, 3(4): 243 – 250. 2009. Cited by: 4
Immunomodulating effects of antifungal therapy [link]Paper   doi   link   bibtex  
Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): Stable incidence but changing epidemiology of a still frequently lethal infection. Sipsas, N. V.; Lewis, R. E.; Tarrand, J.; Hachem, R.; Rolston, K. V.; Raad, I. I.; and Kontoyiannis, D. P. Cancer, 115(20): 4745 – 4752. 2009. Cited by: 234
Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): Stable incidence but changing epidemiology of a still frequently lethal infection [link]Paper   doi   link   bibtex  
Azoles and antidepressants: A mini-review of the tolerability of co-administration. Roussos, P.; Lewis, R.; and Kontoyiannis, D. Mycoses, 52(5): 433 – 439. 2009. Cited by: 4
Azoles and antidepressants: A mini-review of the tolerability of co-administration [link]Paper   doi   link   bibtex  
Increased bacterial adherence and biomass in Pseudomonas aeruginosa bacteria exposed to clarithromycin. Garey, K. W.; Vo, Q. P.; Lewis, R. E.; Saengcharoen, W.; LaRocco, M. T.; and Tam, V. H. Diagnostic Microbiology and Infectious Disease, 63(1): 81 – 86. 2009. Cited by: 16
Increased bacterial adherence and biomass in Pseudomonas aeruginosa bacteria exposed to clarithromycin [link]Paper   doi   link   bibtex  
Culture medium composition affects the lethality of Cunninghamella bertholletiae in a fly model of mucormycosis. Pongas, G. N.; Ben-Ami, R.; Lewis, R. E.; Walsh, T. J.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 53(10): 4569. 2009. Cited by: 11; All Open Access, Green Open Access
Culture medium composition affects the lethality of Cunninghamella bertholletiae in a fly model of mucormycosis [link]Paper   doi   link   bibtex  
Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi. Wiederhold, N. P.; and Lewis, R. E. Medical Mycology, 47(4): 422 – 432. 2009. Cited by: 37; All Open Access, Bronze Open Access
Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi [link]Paper   doi   link   bibtex  
Increased virulence of zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis. Lamaris, G. A.; Ben-Ami, R.; Lewis, R. E.; Chamilos, G.; Samonis, G.; and Kontoyiannis, D. P. Journal of Infectious Diseases, 199(9): 1399 – 1406. 2009. Cited by: 113; All Open Access, Bronze Open Access
Increased virulence of zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis [link]Paper   doi   link   bibtex  
Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites. Ben-Ami, R.; Lewis, R. E.; Leventakos, K.; and Kontoyiannis, D. P. Blood, 114(26): 5393 – 5399. 2009. Cited by: 101; All Open Access, Bronze Open Access, Green Open Access
Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites [link]Paper   doi   link   bibtex  
Caspofungin-non-susceptible Candida isolates in cancer patients. Kofteridis, D. P.; Lewis, R. E.; and Kontoyiannis, D. P. Journal of Antimicrobial Chemotherapy, 65(2): 293 – 295. 2009. Cited by: 37; All Open Access, Bronze Open Access
Caspofungin-non-susceptible Candida isolates in cancer patients [link]Paper   doi   link   bibtex  
Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study. Sipsas, N. V.; Lewis, R. E.; Raad, I. I.; and Kontoyiannis, D. P. International Journal of Antimicrobial Agents, 34(1): 95 – 98. 2009. Cited by: 15
Monotherapy with caspofungin for candidaemia in adult patients with cancer: a retrospective, single institution study [link]Paper   doi   link   bibtex  
Overview of the changing epidemiology of candidemia. Lewis, R. E. Current Medical Research and Opinion, 25(7): 1732 – 1740. 2009. Cited by: 81
Overview of the changing epidemiology of candidemia [link]Paper   link   bibtex  
Voriconazole-associated zygomycosis: A significant consequence of evolving antifungal prophylaxis and immunosuppression practices?. Pongas, G.; Lewis, R.; Samonis, G.; and Kontoyiannis, D. Clinical Microbiology and Infection, 15(SUPPL. 5): 93 – 97. 2009. Cited by: 109; All Open Access, Bronze Open Access
Voriconazole-associated zygomycosis: A significant consequence of evolving antifungal prophylaxis and immunosuppression practices? [link]Paper   doi   link   bibtex  
Phaeohyphomycosis in a tertiary care cancer center. Ben-Ami, R.; Lewis, R. E.; Raacl, I. I.; and Kontoyiannis, D. P. Clinical Infectious Diseases, 48(8): 1033 – 1041. 2009. Cited by: 109; All Open Access, Bronze Open Access
Phaeohyphomycosis in a tertiary care cancer center [link]Paper   doi   link   bibtex  
In vivo dynamics of carbapenem-resistant Pseudomonas aeruginosa selection after suboptimal dosing. Tam, V. H.; Ledesma, K. R.; Schilling, A. N.; Lim, T.; Yuan, Z.; Ghose, R.; and Lewis, R. E. Diagnostic Microbiology and Infectious Disease, 64(4): 427 – 433. 2009. Cited by: 17
In vivo dynamics of carbapenem-resistant Pseudomonas aeruginosa selection after suboptimal dosing [link]Paper   doi   link   bibtex  
A clinicopathological study of pulmonary mucormycosis in cancer patients: Extensive angioinvasion but limited inflammatory response. Ben-Ami, R.; Luna, M.; Lewis, R. E.; Walsh, T. J.; and Kontoyiannis, D. P. Journal of Infection, 59(2): 134 – 138. 2009. Cited by: 90; All Open Access, Green Open Access
A clinicopathological study of pulmonary mucormycosis in cancer patients: Extensive angioinvasion but limited inflammatory response [link]Paper   doi   link   bibtex  
Invasive mould infections in the setting of hematopoietic cell transplantation: Current trends and new challenges. Ben-Ami, R.; Lewis, R. E.; and Kontoyiannis, D. P. Current Opinion in Infectious Diseases, 22(4): 376 – 384. 2009. Cited by: 30
Invasive mould infections in the setting of hematopoietic cell transplantation: Current trends and new challenges [link]Paper   doi   link   bibtex  
The Burden of Bacterial and Viral Infections in Hematopoietic Stem Cell Transplant. Kontoyiannis, D. P.; Lewis, R. E.; and Marr, K. Biology of Blood and Marrow Transplantation, 15(1 SUPPL.): 128 – 133. 2009. Cited by: 20; All Open Access, Hybrid Gold Open Access
The Burden of Bacterial and Viral Infections in Hematopoietic Stem Cell Transplant [link]Paper   doi   link   bibtex  
Invasive aspergillosis in glucocorticoid-treated patients. Lewis, R. E.; and Kontoyiannis, D. P. Medical Mycology, 47(SUPPL. 1): S271–S281. 2009. Cited by: 96; All Open Access, Bronze Open Access
Invasive aspergillosis in glucocorticoid-treated patients [link]Paper   doi   link   bibtex  
  2008 (14)
Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Chamilos, G.; Lewis, R. E.; and Kontoyiannis, D. P. Clinical Infectious Diseases, 47(4): 503 – 509. 2008. Cited by: 629; All Open Access, Bronze Open Access
Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis [link]Paper   doi   link   bibtex  
Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis. Lewis, R. E.; Albert, N. D.; and Kontoyiannis, D. P. Journal of Antimicrobial Chemotherapy, 61(5): 1140 – 1144. 2008. Cited by: 52; All Open Access, Bronze Open Access
Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis [link]Paper   doi   link   bibtex  
Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Chamilos, G.; Lewis, R. E.; Hu, J.; Xiao, L.; Zal, T.; Gilliet, M.; Halder, G.; and Kontoyiannis, D. P. Proceedings of the National Academy of Sciences of the United States of America, 105(27): 9367 – 9372. 2008. Cited by: 118; All Open Access, Green Open Access
Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis [link]Paper   doi   link   bibtex  
What is the "therapeutic range" for voriconazole?. Lewis, R. E. Clinical Infectious Diseases, 46(2): 212 – 214. 2008. Cited by: 43; All Open Access, Bronze Open Access
What is the "therapeutic range" for voriconazole? [link]Paper   doi   link   bibtex  
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae. Chamilos, G.; Lewis, R. E.; Lamaris, G. A.; Albert, N. D.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 52(4): 1325 – 1329. 2008. Cited by: 9; All Open Access, Green Open Access
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae [link]Paper   doi   link   bibtex  
Candida lusitaniae fungemia in cancer patients: Risk factors for amphotericin B failure and outcome. Atkinson, B. J.; Lewis, R. E.; and Kontoyiannis, D. P. Medical Mycology, 46(6): 541 – 546. 2008. Cited by: 84; All Open Access, Bronze Open Access
Candida lusitaniae fungemia in cancer patients: Risk factors for amphotericin B failure and outcome [link]Paper   doi   link   bibtex  
Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage. Chamilos, G.; Lewis, R.; Lamaris, G.; Walsh, T.; and Kontoyiannis, D. Antimicrobial Agents and Chemotherapy, 52(2): 722 – 724. 2008. Cited by: 89; All Open Access, Green Open Access
Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage [link]Paper   doi   link   bibtex  
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis. Kontoyiannis, D. P.; Lewis, R. E.; Alexander, B. D.; Lortholary, O.; Dromer, F.; Gupta, K. L.; John, G. T.; Del Busto, R.; Klintmalm, G. B.; Somani, J.; Lyon, G. M.; Pursell, K.; Stosor, V.; Muňoz, P.; Limaye, A. P.; Kalil, A. C.; Pruett, T. L.; Garcia-Diaz, J.; Humar, A.; Houston, S.; House, A. A.; Wray, D.; Orloff, S.; Dowdy, L. A.; Fisher, R. A.; Heitman, J.; Albert, N. D.; Wagener, M. M.; and Singh, N. Antimicrobial Agents and Chemotherapy, 52(2): 735 – 738. 2008. Cited by: 79; All Open Access, Green Open Access
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis [link]Paper   doi   link   bibtex  
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies. Garcia-Effron, G.; Kontoyiannis, D. P.; Lewis, R. E.; and Perlin, D. S. Antimicrobial Agents and Chemotherapy, 52(11): 4181 – 4183. 2008. Cited by: 115; All Open Access, Green Open Access
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies [link]Paper   doi   link   bibtex  
Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis. Lamaris, G.; Ben-Ami, R.; Lewis, R.; and Kontoyiannis, D. Journal of Antimicrobial Chemotherapy, 62(3): 539 – 542. 2008. Cited by: 17
Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis [link]Paper   doi   link   bibtex  
Immunopharmacology of modern antifungals. Ben-Ami, R.; Lewis, R.; and Kontoyiannis, D. Clinical Infectious Diseases, 47(2): 226 – 235. 2008. Cited by: 128; All Open Access, Bronze Open Access
Immunopharmacology of modern antifungals [link]Paper   doi   link   bibtex  
Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis. Lewis, R. E.; Albert, N. D.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 52(11): 4178 – 4180. 2008. Cited by: 22; All Open Access, Green Open Access
Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis [link]Paper   doi   link   bibtex  
Caspofungin-mediated β-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. Lamaris, G. A.; Lewis, R. E.; Chamilos, G.; May, G. S.; Safdar, A.; Walsh, T. J.; Raad, I. I.; and Kontoyiannis, D. P. Journal of Infectious Diseases, 198(2): 186 – 192. 2008. Cited by: 174; All Open Access, Bronze Open Access, Green Open Access
Caspofungin-mediated β-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae [link]Paper   doi   link   bibtex  
Fungal endophthalmitis in a tertiary care cancer center: A review of 23 cases. Lamaris, G.; Esmaeli, B.; Chamilos, G.; Desai, A.; Chemaly, R.; Raad, I.; Safdar, A.; Lewis, R.; and Kontoyiannis, D. European Journal of Clinical Microbiology and Infectious Diseases, 27(5): 343 – 347. 2008. Cited by: 46
Fungal endophthalmitis in a tertiary care cancer center: A review of 23 cases [link]Paper   doi   link   bibtex  
  2007 (13)
Increased culture recovery of zygomycetes under physiologic temperature conditions. Kontoyiannis, D. P.; Chamilos, G.; Hassan, S. A.; Lewis, R. E.; Albert, N. D.; and Tarrand, J. J. American Journal of Clinical Pathology, 127(2): 208 – 212. 2007. Cited by: 51; All Open Access, Bronze Open Access
Increased culture recovery of zygomycetes under physiologic temperature conditions [link]Paper   doi   link   bibtex  
Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Kontoyiannis, D. P.; Chamilos, G.; Lewis, R. E.; Giralt, S.; Cortes, J.; Raad, I. I.; Manning, J. T.; and Han, X. Cancer, 110(6): 1303 – 1306. 2007. Cited by: 138
Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation [link]Paper   doi   link   bibtex  
Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: A retrospective, nonrandomized autopsy study. Chamilos, G.; Luna, M.; Lewis, R. E.; Chemaly, R.; Raad, I. I.; and Kontoyiannis, D. P. Clinical Therapeutics, 29(9): 1980 – 1986. 2007. Cited by: 29
Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: A retrospective, nonrandomized autopsy study [link]Paper   doi   link   bibtex  
Paradoxical effect of echinocandins across Candida species in vitro: Evidence for Echinocandin-Specific and Candida species-related differences. Chamilos, G.; Lewis, R. E.; Albert, N.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 51(6): 2257 – 2259. 2007. Cited by: 163; All Open Access, Green Open Access
Paradoxical effect of echinocandins across Candida species in vitro: Evidence for Echinocandin-Specific and Candida species-related differences [link]Paper   doi   link   bibtex  
Role of mini-host models in the study of medically important fungi. Chamilos, G.; Lionakis, M. S; Lewis, R. E; and Kontoyiannis, D. P Lancet Infectious Diseases, 7(1): 42 – 55. 2007. Cited by: 79
Role of mini-host models in the study of medically important fungi [link]Paper   doi   link   bibtex  
Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster. Lamaris, G. A.; Chamilos, G.; Lewis, R. E.; and Kontoyiannis, D. P. Journal of Infectious Diseases, 196(12): 1860 – 1864. 2007. Cited by: 41; All Open Access, Bronze Open Access
Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster [link]Paper   doi   link   bibtex  
Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: Implications for the pathogenesis of invasive aspergillosis. Orciuolo, E.; Stanzani, M.; Canestraro, M.; Galimberti, S.; Carulli, G.; Lewis, R.; Petrini, M.; and Komanduri, K. V. Journal of Leukocyte Biology, 82(4): 839 – 848. 2007. Cited by: 60
Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: Implications for the pathogenesis of invasive aspergillosis [link]Paper   doi   link   bibtex  
Pharmacodynamic implications for use of antifungal agents. Lewis, R. E Current Opinion in Pharmacology, 7(5): 491 – 497. 2007. Cited by: 32
Pharmacodynamic implications for use of antifungal agents [link]Paper   doi   link   bibtex  
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients. Chou, L. S.; Lewis, R. E.; Ippoliti, C.; Champlin, R. E.; and Kontoyiannis, D. P. Pharmacotherapy, 27(12 I): 1644 – 1650. 2007. Cited by: 63
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients [link]Paper   doi   link   bibtex  
Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice. Lewis, R. E.; Chamilos, G.; Prince, R. A.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 51(3): 1078 – 1081. 2007. Cited by: 40; All Open Access, Green Open Access
Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice [link]Paper   doi   link   bibtex  
Random plasma concentrations of voriconazole decline over time. Mulanovich, V.; Lewis, R. E.; Raad, I. I.; and Kontoyiannis, D. P. Journal of Infection, 55(5): e129–e130. 2007. Cited by: 28
Random plasma concentrations of voriconazole decline over time [link]Paper   doi   link   bibtex  
Multidrug-resistant endosymbiotic bacteria account for the emergence of zygomycosis: A hypothesis. Chamilos, G.; Lewis, R. E.; and Kontoyiannis, D. P. Fungal Genetics and Biology, 44(2): 88 – 92. 2007. Cited by: 10
Multidrug-resistant endosymbiotic bacteria account for the emergence of zygomycosis: A hypothesis [link]Paper   doi   link   bibtex  
Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis. Lewis, R. E.; Liao, G.; Hou, J.; Chamilos, G.; Prince, R. A.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 51(4): 1253 – 1258. 2007. Cited by: 55; All Open Access, Green Open Access
Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis [link]Paper   doi   link   bibtex  
  2006 (17)
Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. Chamilos, G.; Lionakis, M. S.; Lewis, R. E.; Lopez-Ribot, J. L.; Saville, S. P.; Albert, N. D.; Halder, G.; and Kontoyiannis, D. P. Journal of Infectious Diseases, 193(7): 1014 – 1022. 2006. Cited by: 100; All Open Access, Bronze Open Access
Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species [link]Paper   doi   link   bibtex  
Judgments of value, judgments of fact: The ethical dimension of biohistorical research. Lewis, R. Public Historian, 28(1): 93 – 99. 2006. Cited by: 2
Judgments of value, judgments of fact: The ethical dimension of biohistorical research [link]Paper   doi   link   bibtex  
In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin. Lewis, R. E.; Wiederhold, N. P.; Prince, R. A.; and Kontoyiannis, D. P. Journal of Antimicrobial Chemotherapy, 57(2): 288 – 293. 2006. Cited by: 19; All Open Access, Bronze Open Access
In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin [link]Paper   doi   link   bibtex  
Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47 phox-/- mouse model of chronic granulomatous disease. Dennis, C. G.; Greco, W. R.; Brun, Y.; Youn, R.; Slocum, H. K.; Bernacki, R. J.; Lewis, R.; Wiederhold, N.; Holland, S. M.; Petraitiene, R.; Walsh, T. J.; and Segal, B. H. Antimicrobial Agents and Chemotherapy, 50(2): 422 – 427. 2006. Cited by: 67; All Open Access, Green Open Access
Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47 phox-/- mouse model of chronic granulomatous disease [link]Paper   doi   link   bibtex  
Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis. Wiederhold, N. P.; Tam, V. H.; Chi, J.; Prince, R. A.; Kontoyiannis, D. P.; and Lewis, R. E. Antimicrobial Agents and Chemotherapy, 50(2): 469 – 473. 2006. Cited by: 95; All Open Access, Green Open Access
Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis [link]Paper   doi   link   bibtex  
Erratum: Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species (Journal of Infectious Diseases (2006) 193 (1014-1022)). Chamilos, G.; Lionakis, M.; and Lewis, R. Journal of Infectious Diseases, 194(9): 1342. 2006. Cited by: 1; All Open Access, Bronze Open Access
Erratum: Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species (Journal of Infectious Diseases (2006) 193 (1014-1022)) [link]Paper   doi   link   bibtex  
Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis. Lionakis, M. S.; Chamilos, G.; Lewis, R. E.; Wiederhold, N. P.; Raad, I. I.; Samonis, G.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 50(1): 294 – 297. 2006. Cited by: 12; All Open Access, Green Open Access
Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis [link]Paper   doi   link   bibtex  
Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: An autopsy study over a 15-year period (1989-2003). Chamilos, G.; Luna, M.; Lewis, R. E.; Bodey, G. P.; Chemaly, R.; Tarrand, J. J.; Safdar, A.; Raad, I. I.; and Kontoyiannis, D. P. Haematologica, 91(7): 986 – 989. 2006. Cited by: 454
Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: An autopsy study over a 15-year period (1989-2003) [link]Paper   link   bibtex  
Decision making in antifungal monotherapy versus combination therapy. Lewis, R. E. Pharmacotherapy, 26(6 II): 61S–67S. 2006. Cited by: 8
Decision making in antifungal monotherapy versus combination therapy [link]Paper   doi   link   bibtex  
Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin. Chamilos, G.; Lewis, R. E.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 50(2): 744 – 747. 2006. Cited by: 38; All Open Access, Green Open Access
Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin [link]Paper   doi   link   bibtex  
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: A prospective, multicenter, observational study. Singh, N.; Limaye, A. P.; Forrest, G.; Safdar, N.; Muñoz, P.; Pursell, K.; Houston, S.; Rosso, F.; Montoya, J. G.; Patton, P.; Del Busto, R.; Aguado, J. M.; Fisher, R. A.; Klintmalm, G. B.; Miller, R.; Wagener, M. M.; Lewis, R. E.; Kontoyiannis, D. P.; and Husain, S. Transplantation, 81(3): 320 – 326. 2006. Cited by: 311; All Open Access, Bronze Open Access
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: A prospective, multicenter, observational study [link]Paper   doi   link   bibtex  
Evaluation of antifungals in the surgical intensive care unit: A multi-institutional study. Garey, K. W.; Neuhauser, M. M.; Bearden, D. T.; Cannon, J. P.; Lewis, R. E.; Gentry, L. O.; and Kontoyiannis, D. P. Mycoses, 49(3): 226 – 231. 2006. Cited by: 28
Evaluation of antifungals in the surgical intensive care unit: A multi-institutional study [link]Paper   doi   link   bibtex  
Invasive Zygomycosis: Update on Pathogenesis, Clinical Manifestations, and Management. Kontoyiannis, D. P.; and Lewis, R. E. Infectious Disease Clinics of North America, 20(3): 581 – 607. 2006. Cited by: 215
Invasive Zygomycosis: Update on Pathogenesis, Clinical Manifestations, and Management [link]Paper   doi   link   bibtex  
Managing drug interactions in the patient with aspergillosis. Lewis, R. E. Medical Mycology, 44(SUPPL. 1): 349 – 356. 2006. Cited by: 11; All Open Access, Bronze Open Access
Managing drug interactions in the patient with aspergillosis [link]Paper   doi   link   bibtex  
Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Chamilos, G.; Lewis, R. E.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 50(1): 96 – 103. 2006. Cited by: 113; All Open Access, Green Open Access
Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole [link]Paper   doi   link   bibtex  
Scedosporium infection in a tertiary care cancer center: A review of 25 cases from 1989-2006. Lamaris, G. A.; Chamilos, G.; Lewis, R. E.; Safdar, A.; Raad, I. I.; and Kontoyiannis, D. P. Clinical Infectious Diseases, 43(12): 1580 – 1584. 2006. Cited by: 151; All Open Access, Bronze Open Access
Scedosporium infection in a tertiary care cancer center: A review of 25 cases from 1989-2006 [link]Paper   doi   link   bibtex  
Pharmacology of systemic antifungal agents. Ashley, E. S. D.; Lewis, R.; Lewis, J. S.; Martin, C.; and Andes, D. Clinical Infectious Diseases, 43(SUPPL. 1): S28–S39. 2006. Cited by: 278
Pharmacology of systemic antifungal agents [link]Paper   doi   link   bibtex  
  2005 (17)
Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center. Lewis, R. E.; Wiederhold, N. P.; Lionakis, M. S.; Prince, R. A.; and Kontoyiannis, D. P. Journal of Clinical Microbiology, 43(12): 6120 – 6122. 2005. Cited by: 98; All Open Access, Green Open Access
Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center [link]Paper   doi   link   bibtex  
Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: Difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy. Lionakis, M. S.; Lewis, R. E.; Chamilos, G.; and Kontoyiannis, D. P. Pharmacotherapy, 25(9): 1174 – 1180. 2005. Cited by: 30
Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: Difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy [link]Paper   doi   link   bibtex  
Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Stanzani, M.; Orciuolo, E.; Lewis, R.; Kontoyiannis, D. P.; Martins, S. L. R.; St. John, L. S.; and Komanduri, K. V. Blood, 105(6): 2258 – 2265. 2005. Cited by: 175
Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes [link]Paper   doi   link   bibtex  
Treatment protocols for infections of vascular catheters. Lewis, R. E.; and Raad, I. I. 2005. Cited by: 1
Treatment protocols for infections of vascular catheters [link]Paper   link   bibtex  
Micafungin in combination with voriconazole in Aspergillus species: A pharmacodynamic approach for detection of combined antifungal activity in vitro. Lewis, R. E.; and Kontoyiannis, D. P. Journal of Antimicrobial Chemotherapy, 56(5): 887 – 892. 2005. Cited by: 32; All Open Access, Bronze Open Access
Micafungin in combination with voriconazole in Aspergillus species: A pharmacodynamic approach for detection of combined antifungal activity in vitro [link]Paper   doi   link   bibtex  
In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp. Lewis, R. E.; Wiederhold, N. P.; and Klepser, M. E. Antimicrobial Agents and Chemotherapy, 49(3): 945 – 951. 2005. Cited by: 85; All Open Access, Green Open Access
In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp. [link]Paper   doi   link   bibtex  
Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Lionakis, M. S.; Lewis, R. E.; Torres, H. A.; Albert, N. D.; Raad, I. I.; and Kontoyiannis, D. P. Diagnostic Microbiology and Infectious Disease, 52(1): 15 – 20. 2005. Cited by: 75
Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli [link]Paper   doi   link   bibtex  
Murine model of invasive aspergillosis. Lewis, R. E; and Wiederhold, N. P Methods in molecular medicine, 118: 129 – 142. 2005. Cited by: 31
Murine model of invasive aspergillosis. [link]Paper   doi   link   bibtex  
Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis. Lionakis, M. S.; Lahdenranta, J.; Sun, J.; Liu, W.; Lewis, R. E.; Albert, N. D.; Pasqualini, R.; Arap, W.; and Kontoyiannis, D. P. Infection and Immunity, 73(11): 7747 – 7758. 2005. Cited by: 12; All Open Access, Green Open Access
Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis [link]Paper   doi   link   bibtex  
Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence. Lionakis, M. S.; Lewis, R. E.; May, G. S.; Wiederhold, N. P.; Albert, N. D.; Halder, G.; and Kontoyiannis, D. P. Journal of Infectious Diseases, 191(7): 1188 – 1195. 2005. Cited by: 81
Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence [link]Paper   doi   link   bibtex  
Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Chamilos, G.; Marom, E. M.; Lewis, R. E.; Lionakis, M. S.; and Kontoyiannis, D. P. Clinical Infectious Diseases, 41(1): 60 – 66. 2005. Cited by: 306; All Open Access, Bronze Open Access
Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer [link]Paper   doi   link   bibtex  
Antibacterial activity of linezolid and vancomycin in an vitro pharmacodynamic model of Gram-positive catheter-related bacteraemia. Wiederhold, N. P.; Coyle, E. A.; Raad, I. I.; Prince, R. A.; and Lewis, R. E. Journal of Antimicrobial Chemotherapy, 55(5): 792 – 795. 2005. Cited by: 49; All Open Access, Bronze Open Access
Antibacterial activity of linezolid and vancomycin in an vitro pharmacodynamic model of Gram-positive catheter-related bacteraemia [link]Paper   doi   link   bibtex  
Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa. Tam, V. H.; Schilling, A. N.; Vo, G.; Kabbara, S.; Kwa, A. L.; Wiederhold, N. P.; and Lewis, R. E. Antimicrobial Agents and Chemotherapy, 49(9): 3624 – 3630. 2005. Cited by: 182; All Open Access, Green Open Access
Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa [link]Paper   doi   link   bibtex  
Detection of gliotoxin in experimental and human aspergillosis. Lewis, R. E.; Wiederhold, N. P.; Chi, J.; Han, X. Y.; Komanduri, K. V.; Kontoyiannis, D. P.; and Prince, R. A. Infection and Immunity, 73(1): 635 – 637. 2005. Cited by: 160; All Open Access, Green Open Access
Detection of gliotoxin in experimental and human aspergillosis [link]Paper   doi   link   bibtex  
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: A case-control observational study of 27 recent cases. Kontoyiannis, D. P.; Lionakis, M. S.; Lewis, R. E.; Chamilos, G.; Healy, M.; Perego, C.; Safdar, A.; Kantarjian, H.; Champlin, R.; Walsh, T. J.; and Raad, I. I. Journal of Infectious Diseases, 191(8): 1350 – 1360. 2005. Cited by: 613
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: A case-control observational study of 27 recent cases [link]Paper   doi   link   bibtex  
Attenuation of the activity of caspofungin at high concentrations against Candida albicans: Possible role of cell wall integrity and calcineurin pathways. Wiederhold, N. P.; Kontoyiannis, D. P.; Prince, R. A.; and Lewis, R. E. Antimicrobial Agents and Chemotherapy, 49(12): 5146 – 5148. 2005. Cited by: 120; All Open Access, Green Open Access
Attenuation of the activity of caspofungin at high concentrations against Candida albicans: Possible role of cell wall integrity and calcineurin pathways [link]Paper   doi   link   bibtex  
Vancomycin-resistant Enterococcus faecium: Catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm. Raad, I. I.; Hanna, H. A.; Boktour, M.; Chaiban, G.; Hachem, R. Y.; Dvorak, T.; Lewis, R.; and Murray, B. E. Antimicrobial Agents and Chemotherapy, 49(12): 5046 – 5050. 2005. Cited by: 58; All Open Access, Green Open Access
Vancomycin-resistant Enterococcus faecium: Catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm [link]Paper   doi   link   bibtex  
  2004 (10)
Editorial comment: Is fluconazole the only factor?. Kontoyiannis, D. P.; and Lewis, R. E. Infections in Medicine, 21(1): 40. 2004. Cited by: 0
Editorial comment: Is fluconazole the only factor? [link]Paper   link   bibtex  
Toward more effective antifungal therapy: The prospects of combination therapy. Kontoyiannis, D. P.; and Lewis, R. E. British Journal of Haematology, 126(2): 165 – 175. 2004. Cited by: 75; All Open Access, Bronze Open Access
Toward more effective antifungal therapy: The prospects of combination therapy [link]Paper   doi   link   bibtex  
Novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents. Tam, V. H.; Schilling, A. N.; Lewis, R. E.; Melnick, D. A.; and Boucher, A. N. Antimicrobial Agents and Chemotherapy, 48(11): 4315 – 4321. 2004. Cited by: 33; All Open Access, Green Open Access
Novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents [link]Paper   doi   link   bibtex  
Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: Evidence of concentration-dependent activity. Wiederhold, N. P.; Kontoyiannis, D. P.; Chi, J.; Prince, R. A.; Tam, V. H.; and Lewis, R. E. Journal of Infectious Diseases, 190(8): 1464 – 1471. 2004. Cited by: 195
Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: Evidence of concentration-dependent activity [link]Paper   doi   link   bibtex  
Challenges in designing animal studies to detect antagonism of polyene activity [3] (multiple letters). Lewis, R. E.; Kantoyiannis, D. P.; Najvar, L.; Graybill, J.; and Cacciapuoti, A. Antimicrobial Agents and Chemotherapy, 48(8): 3211 – 3212. 2004. Cited by: 1; All Open Access, Green Open Access
Challenges in designing animal studies to detect antagonism of polyene activity [3] (multiple letters) [link]Paper   doi   link   bibtex  
Erratum: Challenges in designing animal studies to detect antagonism of polyene activity (Antimicrobial Agents and Chemotherapy (2004) 48:8 (3211-3212)). Lewis, R. E.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 48(10): 4072. 2004. Cited by: 0; All Open Access, Green Open Access
Erratum: Challenges in designing animal studies to detect antagonism of polyene activity (Antimicrobial Agents and Chemotherapy (2004) 48:8 (3211-3212)) [link]Paper   doi   link   bibtex  
Constructing Ethical Guidelines for Biohistory. Andrews, L. B.; Buenger, N.; Bridge, J.; Rosenow, L.; Stoney, D.; Gaensslen, R.; Karamanski, T.; Lewis, R.; Paradise, J.; Inlander, A.; and Gonen, D. Science, 304(5668): 215 – 216. 2004. Cited by: 15
Constructing Ethical Guidelines for Biohistory [link]Paper   doi   link   bibtex  
Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: Genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus. Liu, W.; May, G. S.; Lionakis, M. S.; Lewis, R. E.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 48(7): 2490 – 2496. 2004. Cited by: 44; All Open Access, Green Open Access
Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: Genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus [link]Paper   doi   link   bibtex  
Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. Barker, K. S.; Crisp, S.; Wiederhold, N.; Lewis, R. E.; Bareither, B.; Eckstein, J.; Barbuch, R.; Bard, M.; and Rogers, P. D. Journal of Antimicrobial Chemotherapy, 54(2): 376 – 385. 2004. Cited by: 95; All Open Access, Bronze Open Access
Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans [link]Paper   doi   link   bibtex  
Screening of antibacterial and antifungal activities of ten medicinal plants from Ghana. Hoffman, B.; DelasAlas, H.; Blanco, K.; Wiederhold, N.; Lewis, R.; and Williams, L. Pharmaceutical Biology, 42(1): 13 – 17. 2004. Cited by: 30; All Open Access, Bronze Open Access
Screening of antibacterial and antifungal activities of ten medicinal plants from Ghana [link]Paper   doi   link   bibtex  
  2003 (12)
Invasive Aspergillosis in Patients with Hematologic Malignancies. Wiederhold, N. P.; Lewis, R. E.; and Kontoyiannis, D. P. Pharmacotherapy, 23(12 I): 1592 – 1610. 2003. Cited by: 53
Invasive Aspergillosis in Patients with Hematologic Malignancies [link]Paper   doi   link   bibtex  
Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: Evidence of enhanced in vitro activity. Kontoyiannis, D. P.; Lewis, R. E.; Lionakis, M. S.; Albert, N. D.; May, G. S.; and Raad, I. I. Diagnostic Microbiology and Infectious Disease, 47(2): 415 – 419. 2003. Cited by: 16
Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: Evidence of enhanced in vitro activity [link]Paper   doi   link   bibtex  
Attenuation of Itraconazole Fungicidal Activity following Preexposure of Aspergillus fumigatus to Fluconazole. Liu, W.; Lionakis, M. S.; Lewis, R. E.; Wiederhold, N.; May, G. S.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 47(11): 3592 – 3597. 2003. Cited by: 17; All Open Access, Green Open Access
Attenuation of Itraconazole Fungicidal Activity following Preexposure of Aspergillus fumigatus to Fluconazole [link]Paper   doi   link   bibtex  
The solubility ceiling: A rationale for continuous infusion amphotericin B therapy? [9]. Lewis, R. E.; and Wiederhold, N. P. Clinical Infectious Diseases, 37(6): 871 – 872. 2003. Cited by: 42; All Open Access, Bronze Open Access
The solubility ceiling: A rationale for continuous infusion amphotericin B therapy? [9] [link]Paper   doi   link   bibtex  
Pentamidine is active in vitro against Fusarium species. Lionakis, M. S.; Lewis, R. E.; Samonis, G.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 47(10): 3252 – 3259. 2003. Cited by: 25; All Open Access, Green Open Access
Pentamidine is active in vitro against Fusarium species [link]Paper   doi   link   bibtex  
The echinocandin antifungals: An overview of the pharmacology, spectrum and clinical efficacy. Wiederhold, N. P.; and Lewis, R. E. Expert Opinion on Investigational Drugs, 12(8): 1313 – 1333. 2003. Cited by: 135
The echinocandin antifungals: An overview of the pharmacology, spectrum and clinical efficacy [link]Paper   doi   link   bibtex  
Aspergillosis caused by non-fumigatus Aspergillus species: Risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Torres, H. A.; Rivero, G. A.; Lewis, R. E.; Hachem, R.; Raad, I. I.; and Kontoyiannis, D. P. Diagnostic Microbiology and Infectious Disease, 46(1): 25 – 28. 2003. Cited by: 58
Aspergillosis caused by non-fumigatus Aspergillus species: Risk factors and in vitro susceptibility compared with Aspergillus fumigatus [link]Paper   doi   link   bibtex  
Combination chemotherapy for invasive fungal infections: What laboratory and clinical studies tell us so far. Kontoyiannis, D. P.; and Lewis, R. E. Drug Resistance Updates, 6(5): 257 – 269. 2003. Cited by: 53
Combination chemotherapy for invasive fungal infections: What laboratory and clinical studies tell us so far [link]Paper   doi   link   bibtex  
Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. Kontoyiannis, D. P.; Lewis, R. E.; Osherov, N.; Albert, N. D.; and May, G. S. Journal of Antimicrobial Chemotherapy, 51(2): 313 – 316. 2003. Cited by: 109; All Open Access, Bronze Open Access
Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species [link]Paper   doi   link   bibtex  
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Kontoyiannis, D. P.; Hachem, R.; Lewis, R. E.; Rivero, G. A.; Torres, H. A.; Thornby, J.; Champlin, R.; Kantarjian, H.; Bodey, G. P.; and Raad, I. I. Cancer, 98(2): 292 – 299. 2003. Cited by: 281; All Open Access, Bronze Open Access
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies [link]Paper   doi   link   bibtex  
The activity of amphotericin B against Candida albicans is not directly associated with extracellular calcium concentration. Rogers, P. D.; Kramer, R. E.; Crews, J. K.; and Lewis, R. E. Journal of Antimicrobial Chemotherapy, 51(2): 305 – 312. 2003. Cited by: 3; All Open Access, Bronze Open Access
The activity of amphotericin B against Candida albicans is not directly associated with extracellular calcium concentration [link]Paper   doi   link   bibtex  
Candidemia in a Tertiary Care Cancer Center: In vitro susceptibility and its association with outcome of initial antifungal therapy. Antoniadou, A.; Torres, H. A.; Lewis, R. E.; Thornby, J.; Bodey, G. P.; Tarrand, J. J.; Han, X.; Rolston, K. V. I.; Safdar, A.; Raad, I. I.; and Kontoyiannis, D. P. Medicine, 82(5): 309 – 321. 2003. Cited by: 116; All Open Access, Bronze Open Access
Candidemia in a Tertiary Care Cancer Center: In vitro susceptibility and its association with outcome of initial antifungal therapy [link]Paper   doi   link   bibtex  
  2002 (9)
Pharmacotherapy of Candida bloodstream infections: New treatment options, new era. Lewis, R. E. Expert Opinion on Pharmacotherapy, 3(8): 1039 – 1057. 2002. Cited by: 6
Pharmacotherapy of Candida bloodstream infections: New treatment options, new era [link]Paper   doi   link   bibtex  
Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods. Roling, E. E.; Klepser, M. E.; Wasson, A.; Lewis, R. E.; Ernst, E. J.; and Pfaller, M. A. Diagnostic Microbiology and Infectious Disease, 43(1): 13 – 17. 2002. Cited by: 104
Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods [link]Paper   doi   link   bibtex  
Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis. Lewis, R. E.; Prince, R. A.; Chi, J.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 46(10): 3208 – 3214. 2002. Cited by: 81; All Open Access, Green Open Access
Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis [link]Paper   doi   link   bibtex  
Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Lewis, R. E.; Kontoyiannis, D. P.; Darouiche, R. O.; Raad, I. I.; and Prince, R. A. Antimicrobial Agents and Chemotherapy, 46(11): 3499 – 3505. 2002. Cited by: 88; All Open Access, Green Open Access
Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection [link]Paper   doi   link   bibtex  
Aspergillus nidulans is frequently resistant to amphotericin B. Kontoyiannis, D.; Lewis, R.; May, G.; Osherov, N.; and Rinaldi, M. Mycoses, 45(9-10): 406 – 407. 2002. Cited by: 70; All Open Access, Bronze Open Access
Aspergillus nidulans is frequently resistant to amphotericin B [link]Paper   doi   link   bibtex  
Pulmonary candidiasis in patients with cancer: An autopsy study. Kontoyiannis, D.; Reddy, B.; Torres, H.; Luna, M.; Lewis, R.; Tarrand, J.; Bodey, G.; and Raad, I. Clinical Infectious Diseases, 34(3): 400 – 403. 2002. Cited by: 99; All Open Access, Bronze Open Access
Pulmonary candidiasis in patients with cancer: An autopsy study [link]Paper   doi   link   bibtex  
Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth. Lewis, R. E.; Lo, H.; Raad, I. I.; and Kontoyiannis, D. P. Antimicrobial Agents and Chemotherapy, 46(4): 1153 – 1155. 2002. Cited by: 57; All Open Access, Green Open Access
Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth [link]Paper   doi   link   bibtex  
Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. Lewis, R.; Diekema, D.; Messer, S.; Pfaller, M.; and Klepser, M. Journal of Antimicrobial Chemotherapy, 49(2): 345 – 351. 2002. Cited by: 191; All Open Access, Bronze Open Access
Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species [link]Paper   doi   link   bibtex  
Antifungal drug resistance of pathogenic fungi. Kontoyiannis, D. P.; and Lewis, R. E. Lancet, 359(9312): 1135 – 1144. 2002. Cited by: 377
Antifungal drug resistance of pathogenic fungi [link]Paper   doi   link   bibtex  
  2001 (5)
Multi-center evaluation of antifungal time-kill methods. Klepser, M. E.; Lewis, R. E.; Ernst, E. J.; Rosemarie Petzold, C.; Bailey, E. M.; Burgess, D. S.; Carver, P. L.; Lacy, M. K.; Mercier, R.; Nicolau, D. P.; Zhanel, G. G.; and Pfaller, M. A. Journal of Infectious Disease Pharmacotherapy, 5(2): 29 – 41. 2001. Cited by: 9
Multi-center evaluation of antifungal time-kill methods [link]Paper   doi   link   bibtex  
Candida lusitaniae catheter-related sepsis. Pietrucha-Dilanchian, P.; Lewis, R. E.; Ahmad, H.; and Lechin, A. E. Annals of Pharmacotherapy, 35(12): 1570 – 1574. 2001. Cited by: 11
Candida lusitaniae catheter-related sepsis [link]Paper   doi   link   bibtex  
Rationale for combination antifungal therapy. Lewis, R.; and Kontoyiannis, D. Pharmacotherapy, 21(8 SUPPL. 2): 149S–164S. 2001. Cited by: 104
Rationale for combination antifungal therapy [link]Paper   doi   link   bibtex  
Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B. Kontoyiannis, D.; Andersson, B.; Lewis, R.; and Raad, I. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 32(5): E94–96. 2001. Cited by: 17
Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B. [link]Paper   doi   link   bibtex  
Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology. Keele, D. J.; DeLallo, V. C.; Lewis, R. E.; Ernst, E. J.; and Klepser, M. E. Diagnostic Microbiology and Infectious Disease, 41(3): 121 – 126. 2001. Cited by: 34
Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology [link]Paper   doi   link   bibtex  
  2000 (4)
In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methods. Lewis, R. E.; Klepser, M. E.; and Pfaller, M. A. Diagnostic Microbiology and Infectious Disease, 36(2): 101 – 105. 2000. Cited by: 47
In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methods [link]Paper   doi   link   bibtex  
Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: An E-test-based strategy. Kontoyiannis, D.; Lewis, R.; Sagar, N.; May, G.; Prince, R.; and Rolston, K. Antimicrobial Agents and Chemotherapy, 44(10): 2915 – 2918. 2000. Cited by: 68; All Open Access, Green Open Access
Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: An E-test-based strategy [link]Paper   doi   link   bibtex  
Evaluation of voriconazole pharmacodynamics using time-kill methodology. Klepser, M. E.; Malone, D.; Lewis, R. E.; Ernst, E. J.; and Pfaller, M. A. Antimicrobial Agents and Chemotherapy, 44(7): 1917 – 1920. 2000. Cited by: 102; All Open Access, Green Open Access
Evaluation of voriconazole pharmacodynamics using time-kill methodology [link]Paper   doi   link   bibtex  
Comparison of oral immediate-release (IR) and extended-release (ER) metronidazole bactericidal activity against Bacteroides spp. using an in vitro model of infection. Lewis, R. E.; Klepser, M. E.; Ernst, E. J.; Snabes, M. A.; and Jones, R. Diagnostic Microbiology and Infectious Disease, 37(1): 51 – 55. 2000. Cited by: 9
Comparison of oral immediate-release (IR) and extended-release (ER) metronidazole bactericidal activity against Bacteroides spp. using an in vitro model of infection [link]Paper   doi   link   bibtex  
  1999 (3)
Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection. Lewis, R. E.; Klepser, M. E.; Ernst, E. J.; Lund, B. C.; Biedenbach, D. J.; and Jones, R. N. Antimicrobial Agents and Chemotherapy, 43(8): 2005 – 2009. 1999. Cited by: 24; All Open Access, Bronze Open Access, Green Open Access
Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection [link]Paper   doi   link   bibtex  
The changing face of nosocomial candidemia: Epidemiology, resistance, and drug therapy. Lewis, R. E.; and Klepser, M. E. American Journal of Health-System Pharmacy, 56(6): 525 – 536. 1999. Cited by: 44; All Open Access, Bronze Open Access
The changing face of nosocomial candidemia: Epidemiology, resistance, and drug therapy [link]Paper   doi   link   bibtex  
Combination systemic antifungal therapy for cryptococcosis, candidiasis, and aspergillosis. Lewis, R.; Klepser, M.; and Pfaller, M. Journal of Infectious Disease Pharmacotherapy, 3(4): 61 – 83. 1999. Cited by: 19
Combination systemic antifungal therapy for cryptococcosis, candidiasis, and aspergillosis [link]Paper   doi   link   bibtex  
  1998 (5)
Update on clindamycin: New pharmacokinetic and pharmacodynamic data. Lewis, R. E.; and Klepser, M. E. Infections in Medicine, 15(10): 726 – 731. 1998. Cited by: 3
Update on clindamycin: New pharmacokinetic and pharmacodynamic data [link]Paper   link   bibtex  
Assessment of antifungal activities of fluconazole and amphotericin b administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model. Lewis, R. E.; Lund, B. C.; Klepser, M. E.; Ernst, E. J.; and Pfaller, M. A. Antimicrobial Agents and Chemotherapy, 42(6): 1382 – 1386. 1998. Cited by: 89; All Open Access, Bronze Open Access, Green Open Access
Assessment of antifungal activities of fluconazole and amphotericin b administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model [link]Paper   doi   link   bibtex  
Therapy of Candida infections: Susceptibility testing, resistance, and therapeutic options. Klepser, M. E.; Lewis, R. E.; and Pfaller, M. A. Annals of Pharmacotherapy, 32(12): 1353 – 1361. 1998. Cited by: 23
Therapy of Candida infections: Susceptibility testing, resistance, and therapeutic options [link]Paper   doi   link   bibtex  
Influence of test conditions on antifungal time-kill curve results: Proposal for standardized methods. Klepser, M. E.; Ernst, E. J.; Lewis, R. E.; Ernst, M. E.; and Pfaller, M. A. Antimicrobial Agents and Chemotherapy, 42(5): 1207 – 1212. 1998. Cited by: 286; All Open Access, Green Open Access
Influence of test conditions on antifungal time-kill curve results: Proposal for standardized methods [link]Paper   doi   link   bibtex  
Update on clinical antifungal susceptibility testing for Candida species. Lewis, R. E.; Klepser, M. E.; and Pfaller, M. A. Pharmacotherapy, 18(3): 509 – 515. 1998. Cited by: 13
Update on clinical antifungal susceptibility testing for Candida species [link]Paper   doi   link   bibtex  
  undefined (5)
. . .
link   bibtex   9 downloads  
. . .
link   bibtex   9 downloads  
. . .
link   bibtex   9 downloads  
. . .
link   bibtex   9 downloads  
. . .
link   bibtex   9 downloads